Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9)

Critical Reviews in Biochemistry and Molecular Biology

Volumn 37, Issue 6, 2002, Pages 375-536

  Van Den Steen, Philippe E ^b   Dubois, Bénédicte ^b   Nelissen, Inge ^b   Rudd, Pauline M ^b   Dwek, Raymond A ^b   Opdenakker, Ghislain ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GELATINASE B; GROWTH FACTOR; HORMONE; MITOGEN ACTIVATED PROTEIN KINASE; PHORBOL ESTER; TRANSFORMING GROWTH FACTOR BETA;

ARTHRITIS; COMPLEX FORMATION; DEGENERATIVE DISEASE; DIGESTIVE SYSTEM INFLAMMATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME STABILITY; ENZYME STRUCTURE; GLYCOSYLATION; GROWTH; HUMAN; INFECTION; INFLAMMATION; INFLAMMATORY DISEASE; LEUKOCYTE ACTIVATION; NEPHRITIS; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; PATHOGENESIS; PNEUMONIA; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FAMILY; PROTEIN FUNCTION; REGULATORY MECHANISM; REPRODUCTION; REVIEW; SIGNAL TRANSDUCTION; SKIN INFLAMMATION; TRANSCRIPTION REGULATION; VASCULAR DISEASE; WOUND HEALING;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MATRIX METALLOPROTEINASE 9; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STRUCTURE, TERTIARY;

EID: 0038059516     PISSN: 10409238     EISSN: None     Source Type: Journal    
DOI: 10.1080/10409230290771546     Document Type: Review

References (799)

1. Abu El-Asrar, A. M., Dralands, L., Veckeneer, M., Geboes, K., Missotten, L., Van Aelst, I., and Opdenakker, G. 1998. Gelatinase B in proliferative vitreoretinal disorders. Am. J. Ophthalmol. 125: 844-851.
2. Abu El-Asrar, A. M., Geboes, K., Al-Kharashi, S. A., Al-Mosallam, A. A., Missotten, L., Paemen, L., and Opdenakker, G. 2000. Expression of gelatinase B in trachomatous conjunctivitis. Br. J. Ophthalmol. 84: 85-91.
3. Agarwal, C., Hembree, J. R., Rorke, E. A., and Eckert, R. L. 1994. Transforming growth factor beta 1 regulation of metalloproteinase production in cultured human cervical epithelial cells. Cancer Res. 54: 943-949.
4. Agren, M. S. 1994. Gelatinase activity during wound healing. Br. J. Dermatol. 131: 634-640.
5. Agrez, M., Gu, X., Turton, J., Meldrum, C., Niu, J., Antalis, T., and Howard, E. W. 1999. The alpha v beta 6 integrin induces gelatinase B secretion in colon cancer cells. Int. J. Cancer 81: 90-97.
6. Ahmed, N., Pansino, F., Baker, M., Rice, G., and Quinn, M. 2002a. Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. J. Cell Biochem. 84: 675-686.
7. Ahmed, N., Pansino, F., Clyde, R., Murthi, P., Quinn, M. A., Rice, G. E., Agrez, M. V., Mok, S., and Baker, M. S. 2002b. Overexpression of alpha(v)beta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis 23: 237-244.
8. Ahrens, D., Koch, A. E., Pope, R. M., Stein-Picarella, M., and Niedbala, M. J. 1996. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis. Arthritis Rheum. 39: 1576-1587.
9. Albini, A., D'Agostini, F., Giunciugho, D., Paglieri, I., Balansky, R., and De Flora, S. 1995. Inhibition of invasion, gelatinase activity, tumor take and metastasis of malignant cells by N-acetylcysteine. Int. J. Cancer 61: 121-129.
10. Alexander, C. M., Hansell, E. J., Behrendtsen, O., Flannery, M. L., Kishnani, N. S., Hawkes, S. P., and Werb, Z. 1996. Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 122: 1723-1736.
11. Allan, J. A., Docherty, A. J., Barker, P. J., Huskisson, N. S., Reynolds, J. J., and Murphy, G. 1995. Binding of gelatinases A and B to type-I collagen and other matrix components. Biochem. J. 309: 299-306.
12. Allport, J. R., Lim, Y. C., Shipley, J. M., Senior, R. M., Shapiro, S. D., Matsuyoshi, N., Vestweber, D., and Luscinskas, F. W. 2002. Neutrophils from MMP-9- or neutrophil elastase-deficient mice show no defect in transendothelial migration under flow in vitro. J. Leukoc. Biol. 71: 821-828.
13. Amorino, G. P. and Hoover, R. L. 1998. Interactions of monocytic cells with human endothelial cells stimulate monocytic metalloproteinase production. Am. J. Pathol. 152: 199-207.
14. Andreasen, P. A., Pyke, C., Riccio, A., Kristensen, P., Nielsen, L. S., Lund, L. R., Blasi, F., and Dano, K. 1987. Plasminogen activator inhibitor type 1 biosynthesis and mRNA level are increased by dexamethasone in human fibrosarcoma cells. Mol. Cell Biol. 7: 3021-3025.
15. Andrews, K. L., Betsuyaku, T., Rogers, S., Shipley, J. M., Senior, R. M., and Miner, J. H. 2000. Gelatinase B (MMP-9) is not essential in the normal kidney and does not influence progression of renal disease in a mouse model of Alport syndrome. Am. J. Pathol. 157: 303-311.
16. Angel, P., Imagawa, M., Chiu, R., Stein, B., Imbra, R. J., Rahmsdorf, H. J., Jonat, C., Herrlich, P., and Karin, M. 1987. Phorbol ester-inducible genes contain a common cis-element recognized by a TPA-modulated trans-acting factor. Cell 49: 729-739.
17. Anthony, D. C., Ferguson, B., Matyzak, M. K., Miller, K. M., Esiri, M. M., and Perry, V. H. 1997. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23: 406-415.
18. Aoudjit, F., Potworowski, E. F., and St-Pierre, Y. 1998. Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1. J. Immunol. 160: 2967-2973.
19. Apodaca, G., Rutka, J. T., Bouhana, K., Berens, M. E., Giblin, J. R., Rosenblum, M. L., McKerrow, J. H., and Banda, M. J. 1990. Expression of metalloproteinases and metalloproteinase inhibitors by fetal astrocytes and glioma cells. Cancer Res. 50: 2322-2329.
20. Ara, T., Deyama, Y., Yoshimura, Y., Higashino, F., Shindoh, M., Matsumoto, A., and Fukuda, H. 2000. Membrane type 1-matrix metalloproteinase expression is regulated by E-cadherin through the suppression of mitogen-activated protein kinase cascade. Cancer Lett. 157: 115-121.
21. Asahi, M., Sumii, T., Fini, M. E., Itohara, S., and Lo, E. H. 2001a. Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia. Neuroreport 12: 3003-3007.
22. Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J. C., Moskowitz, M. A., Fini, M. E., and Lo, E. H. 2001b. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J. Neurosci. 21: 7724-7732.
23. Athayde, N., Romero, R., Gomez, R., Maymon, E., Pacora, P., Mazor, M., Yoon, B. H., Fortunato, S., Menon, R., Ghezzi, F., and Edwin, S. S. 1999. Matrix metalloproteinases-9 in preterm and term human parturition. J. Matern. Fetal Med. 8: 213-219.
24. Azuma, M., Aota, K., Tamatani, T., Motegi, K., Yamashita, T., Harada, K., Hayashi, Y., and Sato, M. 2000. Suppression of tumor necrosis factor alpha-induced matrix metalloproteinase 9 production by the introduction of a super-repressor form of inhibitor of nuclear factor kappaBalpha complementary DNA into immortalized human salivary gland acinar cells. Prevention of the destruction of the acinar structure in Sjogren's syndrome salivary glands. Arthritis Rheum. 43: 1756-1767.
25. Backstrom, J. R., Lim, G. P., Cullen, M. J., and Tökés, Z. A. 1996. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-β peptide (1-40). J. Neurosci. 16: 7910-7919.
26. Backstrom, J. R. and Tökés, Z. A. 1995. The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. J. Neurochem. 64: 1312-1318.
27. Bafetti, L. M., Young, T. N., Itoh, Y., and Stack, M. S. 1998. Intact vitronectin induces matrix metalloproteinase-2 and tissue inhibitor of metalloproteinases-2 expression and enhanced cellular invasion by melanoma cells. J. Biol. Chem. 273: 143-149.
28. Bailey, C. J., Hembry, R. M., Alexander, A., Irving, M. H., Grant, M. E., and Shuttleworth, C. A. 1994. Distribution of the matrix metalloproteinases stromelysin, gelatinases A and B, and collagenase in Crohn's disease and normal intestine. J. Clin. Pathol. 47: 113-116.
29. Ballin, M., Gomez, D. E., Sinha, C. C., and Thorgeirsson, U. P. 1988. Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype. Biochem. Biophys. Res. Commun. 154: 832-838.
30. Bannikov, G. A., Karelina, T. V., Collier, I. E., Manner, B. L., and Goldberg, G. I. 2002. Substrate binding of gelatinase B induces its enzymatic activity in the presence of intact propeptide. J. Biol. Chem. 277: 16022-16027.
31. Baragi, V. M., Qiu, L., Gunja-Smith, Z., Woessner, Jr, J. F., Lesch, C. A., and Guglietta, A. 1997. Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats. Scand. J. Gastroenterol. 32: 419-426.
32. Baram, D., Vaday, G. G., Salamon, P., Drucker, I., Hershkoviz, R., and Mekori, Y. A. 2001. Human mast cells release metalloproteinase-9 on contact with activated T cells: juxtacrine regulation by TNF-alpha. J. Immunol. 167: 4008-4016.
33. Barille, S., Akhoundi, C., Collette, M., Mellerin, M. P., Rapp, M. J., Harousseau, J. L., Bataille, R., and Amiot, M. 1997. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9 (MMP-9), activation of progelatinase A, and induction of MMP-1 by myeloma cells. Blood 90: 1649-1655.
34. Bartholomé, E. J., Van Aelst, I., Koyen, E., Kiss, R., Willems, F., Goldman, M., and Opdenakker, G. 2001. Human monocyte-derived dendritic cells produce bioactive gelatinase B: inhibition by IFN-beta. J. Interferon. Cytokine. Res. 21: 495-501.
35. Baud, V. and Karin, M. 2001. Signal transduction by tumor necrosis factor and its relatives. Trends. Cell Biol. 11: 372-377.
36. Baylis, H. A., Megson, A., and Hall, R. 1995. Infection with Theileria annulata induces expression of matrix metalloproteinase 9 and transcription factor AP-1 in bovine leucocytes. Mol. Biochem. Parasitol. 69: 211-222.
37. Behrendtsen, O., Alexander, C. M., and Werb, Z. 1992. Metalloproteinases mediate extracellular matrix degradation by cells from mouse blastocyst outgrowths. Development 114: 447-456.
38. Belaaouaj, A. A., Li, A., Wun, T. C., Welgus, H. G., and Shapiro, S. D. 2000. Matrix metalloproteinases cleave tissue factor pathway inhibitor. Effects on coagulation. J. Biol. Chem. 275: 27123-27128.
39. Belkhiri, A., Richards, C., Whaley, M., McQueen, S. A., and Orr, F. W. 1997. Increased expression of activated matrix metalloproteinase-2 by human endothelial cells after sublethal H2O2 exposure. Lab. Invest. 77: 533-539.
40. Benbow, U. and Brinckerhoff, C. E. 1997. The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biol. 15: 519-526.
41. Bendeck, M. P., Irvin, C., and Reidy, M. A. 1996. Inhibition of matrix metalloproteinase activity inhibits smooth muscle cell migration but not neointimal thickening after arterial injury. Circ. Res. 78: 38-43.
42. Bendeck, M. P., Irvin, C., Reidy, M. A., Smith, L., Mulholland, D., Horton, M., Giachelli, C.M. 2000. Smooth muscle cell matrix metalloproteinase production is stimulated via alpha(v)beta(3) integrin. Arterioscler. Thromb. Vasc. Biol. 20: 1467-1472.
43. Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E., and Reidy, M. A. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75: 539-545.
44. Beppu, M., Ikebe, T., and Shirasuna, K. 2002. The inhibitory effects of immunosuppressive factors, dexamethasone and interleukin-4, on NF-kappaB-mediated protease production by oral cancer. Biochim. Biophys. Acta 1586: 11-22.
45. Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., and Hanahan, D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat. Cell Biol. 2: 737-744.
46. Bernhard, E. J., Gruber, S. B., and Muschel, R. J. 1994. Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells. Proc. Natl. Acad. Sci. U. S. A. 91: 4293-4297.
47. Bernhard, E. J., Muschel, R. J., and Hughes, E. N. 1990. Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res. 50: 3872-3877.
48. Bertaux, B., Hornebeck, W., Eisen, A. Z., and Dubertret, L. 1991. Growth stimulation of human keratinocytes by tissue inhibitor of metalloproteinases. J. Invest. Dermatol. 97: 679-685.
49. Betsuyaku, T., Nishimura, M., Takeyabu, K., Tanino, M., Venge, P., Xu, S., and Kawakami, Y. 1999a. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am. J. Respir. Crit. Care Med. 159: 1985-1991.
50. Betsuyaku, T., Shipley, J. M., Liu, Z., and Senior, R. M. 1999b. Neutrophil emigration in the lungs, peritoneum, and skin does not require gelatinase B. Am. J. Respir. Cell Mol. Biol. 20: 1303-1309.
51. Betsuyaku, T., Shipley, J. M., Liu, Z., and Senior, R. M. 1999c. Gelatinase B deficiency does not protect against lipopolysaccharide-induced acute lung injury. Chest 116: 17S-18S.
52. Betsuyaku, T., Fukuda, Y., Parks, W. C., Shipley, J. M., and Senior, R. M. 2000. Gelatinase B is required for alveolar bronchiolization after intratracheal bleomycin. Am. J. Pathol. 157: 525-535.
53. Bian, J., and Sun, Y. 1997. Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter. Mol. Cell Biol. 17: 6330-6338.
54. Bigg, H. F., Shi, Y. E., Liu, Y. E., Steffensen, B., and Overall, C. M. 1997. Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2. J. Biol. Chem. 272: 15496-15500.
55. Birkedal-Hansen, H., Moore, W. G., Bodden, M. K., Windsor, L. J., Birkedal-Hansen, B., DeCarlo, A., and Engler, J. A. 1993. Matrix metalloproteinases: a review. Crit. Rev. Oral Biol. Med. 4: 197-250.
56. Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S., and Tschesche, H. 1994. The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J. 13: 1263-1269.
57. Bond, M., Chase, A. J., Baker, A. H., and Newby, A. C. 2001. Inhibition of transcription factor NF-kappaB reduces matrix metalloproteinase-1, -3 and -9 production by vascular smooth muscle cells. Cardiovasc. Res. 50: 556-565.
58. Bond, M., Fabunmi, R. P., Baker, A. H., and Newby, A. C. 1998. Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B. FEBS Lett. 435: 29-34.
59. Bottles, K. D., Bullen, E. C., Updike, D. L., Vu, T. K., Phelps, E., Grammas, P., and Howard, E. W. 1999. Gelatinase A expression in endothelial cells is regulated by at least two cis-acting promoter elements. Biochim. Biophys. Acta 1428: 147-160.
60. (3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells. J. Cell Physiol. 176: 206-215.
61. Boyd, R. S. and Balkwill, F. R. 1999. MMP-2 release and activation in ovarian carcinoma: the role of fibroblasts. Br. J. Cancer 80: 315-321.
62. Brandt, E., Petersen, F., and Flad, H. D. 1992. Recombinant tumor necrosis factor-α potentiates neutrophil degranulation in response to host defense cytokines neutrophil-activating peptide 2 and IL-8 by modulating intracellular cyclic AMP levels. J. Immunol. 149: 1356-1364.
63. Braunhut, S. J. and Moses, M. A. 1994. Retinoids modulate endothelial cell production of matrix-degrading proteases and tissue inhibitors of metalloproteinases (TIMP). J. Biol. Chem. 269: 13472-13479.
64. Broberg, A., Nissinen, L., Potila, M., and Heino, J. 2001. Three-dimensional collagen regulates collagen gene expression by a mechanism that requires serine/threonine kinases and is independent of mechanical contraction. Biochem. Biophys. Res. Commun. 280: 328-333.
65. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T., Aimes, R. T., Stetler, S. W., Quigley, J. P., and Cheresh, D. A. 1996. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3. Cell 85: 683-693.
66. Brosnan, C. F., Cammer, W., Norton, W. T., and Bloom, B. R. 1980. Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis. Nature 285: 235-237.
67. Brown, D. L., Hibbs, M. S., Kearney, M., Loushin, C., and Isner, J. M. 1995. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation 91: 2125-2131.
68. Brown, P. D., Levy, A. T., Margulies, I. M., Liotta, L. A., and Stetler-Stevenson, W. G. 1990. Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50: 6184-6191.
69. 2+ in activation and catalysis. J. Biol. Chem. 270: 18563-18569.
70. Buisson, A. -C., Zahm, J. -M., Polette, M., Pierrot, D., Bellon, G., Puchelle, E., Birembaut, P., and Tournier, J. -M. 1996. Gelatinase B is involved in the in vitro wound repair of human respiratory epithelium. J. Cell Physiol. 166: 413-426.
71. Bullen, E. C., Longaker, M. T., Updike, D. L., Benton, R., Ladin, D., Hou, Z., and Howard, E. W. 1995. Tissue inhibitor of metalloproteinases-1 is decreased and activated gelatinases are increased in chronic wounds. J. Invest. Dermatol. 104: 236-240.
72. Butler, G. S., Apte, S. S., Willenbrock, F., and Murphy, G. 1999. Human tissue inhibitor of metalloproteinases 3 interacts with both the N- and C-terminal domains of gelatinases A and B. Regulation by polyanions. J. Biol. Chem. 274: 10846-10851.
73. Butler, G. S., Sim, D., Tam, E., Devine, D., and Overall, C. M. 2002. Mannose-binding Lectin (MBL) mutants are susceptible to matrix metalloproteinase proteolysis. potential role in human MBL deficiency. J. Biol. Chem. 277: 17511-17519.
74. Callejas, N. A., Casado, M., Diaz-Guerra, M. J., Bosca, L., and Martin-Sanz, P. 2001. Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology 33: 860-867.
75. Campbell, S. E., Nasir, L., Argyle, D. J., and Bennett, D. 2001. Molecular cloning and characterization of canine metalloproteinase-9 gene promoter. Gene 273: 81-87.
76. Cañete-Soler, R., Litzky, L., Lubensky, I., and Muschel, R. J. 1994. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am. J. Pathol. 144: 518-527.
77. Cañete-Soler, R., Gui, Y. -H., Linask, K. K., and Muschel, R. J. 1995. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization. Brain Res. Dev. Brain Res. 88: 37-52.
78. Cano, E., and Mahadevan, L. C. 1995. Parallel signal processing among mammalian MAPKs. Trends. Biochem. Sci. 20: 117-122.
79. Cha, H. J., Park, M. T., Chung, H. Y., Kim, N. D., Sato, H., Seiki, M., and Kim, K. W. 1998. Ursolic acid-induced down-regulation of MMP-9 gene is mediated through the nuclear translocation of glucocorticoid receptor in HT1080 human fibrosarcoma cells. Oncogene 16: 771-778.
80. Chambaut-Guerin, A. M., Herigault, S., Rouet-Benzine, P., Rouher, C., and Lafuma, C. 2000. Induction of matrix metalloproteinase MMP-9 (92-kDa gelatinase) by retinoic acid in human neuroblastoma SKNBE cells: relevance to neuronal differentiation. J. Neurochem. 74: 508-517.
81. Chang, J. C., Wysocki, A., Tchou-Wong, K. M., Moskowitz, N., Zhang, Y., and Rom, W. N. 1996. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51: 306-311.
82. Chang, L. and Karin, M. 2001. Mammalian MAP kinase signalling cascades. Nature 410: 37-40.
83. Chapel, C., Camara, V., Clayette, P., Salvat, S., Mabondzo, A., Leblond, V., Marcé, D., Lafuma, C., and Dormont, D. 1994. Modulations of 92kDa gelatinase B and its inhibitors are associated with HIV-1 infection in human macrophage cultures. Biochem. Biophys. Res. Commun. 204: 1272-1278.
84. Chapman, H. A. 1997. Plasminogen activators, integrins, and the coordinated regulation of cell adhesion and migration. Curr. Opin. Cell Biol. 9: 714-724.
85. Chen, L. L., Narayanan, R., Hibbs, M. S., Benn, P. A., Clawson, M. L., Lu, G., Rhim, J. S., Greenberg, B., and Mendelsohn, J. 1993. Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes. Biochem. Biophys. Res. Commun. 193: 167-174.
86. Chintala, S. K., Sawaya, R., Aggarwal, B. B., Majumder, S., Giri, D. K., Kyritsis, A. P., Gokaslan, Z. L., and Rao, J. S. 1998. Induction of matrix metalloproteinase-9 requires a polymerized actin cytoskeleton in human malignant glioma cells. J. Biol. Chem. 273: 13545-13551.
87. Chintala, S. K., Sawaya, R., Gokaslan, Z. L., and Rao, J. S. 1996. Modulation of matrix metalloprotease-2 and invasion in human glioma cells by alpha 3 beta 1 integrin. Cancer Lett. 103: 201-208.
88. Chizzolini, C., Rezzonico, R., De Luca, C., Burger, D., and Dayer, J. M. 2000. Th2 cell membrane factors in association with IL-4 enhance matrix metalloproteinase-1 (MMP-1) while decreasing MMP-9 production by granulocyte-macrophage colony-stimulating factor-differentiated human monocytes. J. Immunol. 164: 5952-5960.
89. Cho, A., Graves, J., and Reidy, M. A. 2000. Mitogen-activated protein kinases mediate matrix metalloproteinase-9 expression in vascular smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20: 2527-2532.
90. Chong, Y. H., Sung, J. H., Shin, S. A., Chung, J. H., and Suh, Y. H. 2001. Effects of the beta-amyloid and carboxyl-terminal fragment of Alzheimer's amyloid precursor protein on the production of the tumor necrosis factor-alpha and matrix metalloproteinase-9 by human monocytic THP-1. J. Biol. Chem. 276: 23511-23517.
91. Clark, E. A., and Brugge, J. S. 1995. Integrins and signal transduction pathways: the road taken. Science 268: 233-239.
92. Clements, J. M., Cossins, J. A., Wells, G. M., Corkill, D. J., Helfrich, K., Wood, L. M., Pigott, R., Stabler, G., Ward, G. A., Gearing, A. J., and Miller, K. M. 1997. Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor. J. Neuroimmunol. 74: 85-94.
93. Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Manner, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C. S., Bauer, E. A., and Goldberg, G. I. 1988. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. J. Biol. Chem. 263: 6579-6587.
94. Conant, K., McArthur, J. C., Griffin, D. E., Sjulson, L., Wahl, L. M., and Irani, D. N. 1999. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46: 391-398.
95. Corcoran, M. L., Kibbey, M. C., Kleinman, H. K., and Wahl, L. M. 1995. Laminin SIKVAV peptide induction of monocyte/macrophage prostaglandin E2 and matrix metalloproteinases. J. Biol. Chem. 270: 10365-10368.
96. Corcoran, M. L., Stetler-Stevenson, W. G., Brown, P. D., and Wahl, L. M. 1992. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267: 515-519.
97. Corcoran, M. L., Stetler-Stevenson, W. G., DeWitt, D. L., and Wahl, L. M. 1994. Effect of cholera toxin and pertussis toxin on prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinase production by human monocytes. Arch. Biochem. Biophys. 310: 481-488.
98. Cornelius, L. A., Nehring, L. C., Roby, J. D., Parks, W. C., and Welgus, H. G. 1995. Human dermal microvascular endothelial cells produce matrix metalloproteinases in response to angiogenic factors and migration. J. Invest. Dermatol. 105: 170-176.
99. Cornelius, L. A., Nehring, L. C., Harding, E., Bolanowski, M., Welgus, H. G., Kobayashi, D. K., Pierce, R. A., and Shapiro, S. D. 1998. Matrix metalloproteinases generate angiostatin: effects on neovascularization. J. Immunol. 161: 6845-6852.
100. Coussens, L. M., Tinkle, C. L., Hanahan, D., and Werb, Z. 2000. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103: 481-490.
101. Coussens, L. M., Fingleton, B., and Matrisian, L. M. 2002. Matrix metalloproteinase inhibitors and cancer: trials and tribulations. Science 295: 2387-2392.
102. Cowland, J. B. and Borregaard, N. 1999. The individual regulation of granule protein mRNA levels during neutrophil maturation explains the heterogeneity of neutrophil granules. J. Leukoc. Biol. 66: 989-995.
103. Crabbe, T., Ioannou, C., and Docherty, A. J. 1993. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain. Eur. J. Biochem. 218: 431-438.
104. Crabbe, T., Smith, B., O'Connell, J., and Docherty, A. 1994. Human progelatinase A can be activated by matrilysin. FEBS Lett. 345: 14-16.
105. Créange, A., Sharshar, T., Planchenault, T., Christov, C., Poron, F., Raphael, J. -C., and Gherardi, R. K. 1999. Matrix metalloproteinase-9 is increased and correlates with severity in Guillain-Barré syndrome. Neurology 53: 1683-1691.
106. Crowe, D. L., Tsang, K. J., and Shemirani, B. 2001. Jun N-terminal kinase 1 mediates transcriptional induction of matrix metalloproteinase 9 expression. Neoplasia 3: 27-32.
107. Cuzner, M. L., Gveric, D., Strand, C., Loughlin, A. J., Paemen, L., Opdenakker, G., and Newcombe, J. 1996. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J. Neuropathol. Exp. Neurol. 55: 1194-1204.
108. Cuzner, M. L., McDonald, W. I., Rudge, P., Smith, M., Borshell, N., and Davison, A. N. 1975. Leucocyte proteinase activity and acute multiple sclerosis. J. Neurol. Sci. 26: 107-111.
109. Cuzner, M. L. and Opdenakker, G. 1999. Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system. J. Neuroimmunol. 94: 1-14.
110. Daemi, N., Thomasset, N., Lissitzky, J. C., Dumortier, J., Jacquier, M. F., Pourreyron, C., Rousselle, P., Chayvialle, J. A., and Remy, L. 2000. Anti-beta4 integrin antibodies enhance migratory and invasive abilities of human colon adenocarcinoma cells and their MMP-2 expression. Int. J. Cancer 85: 850-856.
111. Dahlen, B., Shute, J., and Howarth, P. 1999. Immunohistochemical localisation of the matrix metalloproteinases MMP-3 and MMP-9 within the airways in asthma. Thorax 54: 590-596.
112. Davies, B., Waxman, J., Wasan, H., Abel, P., Williams, G., Krausz, T., Neal, D., Thomas, D., Hanby, A., and Balkwill, F. 1993. Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res. 53: 5365-5369.
113. Davis, G. E. and Martin, B. M. 1990. A latent Mr 94,000 gelatin-degrading metalloprotease induced during differentiation of HL-60 promyelocytic leukemia cells: a member of the collagenase family of enzymes. Cancer Res. 50: 1113-1120.
114. Deb, S. and Gottschall, P. E. 1996. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem. 66: 1641-1647.
115. Delacourt, C., Le Bourgeois, M., D'Ortho, M. -P., Doit, C., Scheinmann, P., Navarro, J., Harf, A., Hartmann, D. J., and Lafuma, C. 1995. Imbalance between 95 kDa type IV collagenase and tissue inhibitor of metalloproteinases in sputum of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 152: 765-774.
116. Delclaux, C., Delacourt, C., D'Ortho, M. P., Boyer, V., Lafuma, C., and Harf, A. 1996. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membrane. Am. J. Respir. Cell Mol. Biol. 14: 288-295.
117. Desrivières, S., Lu, H., Peyri, N., Soria, C., Legrand, Y., and Menashi, S. 1993. Activation of the 92 kDa type IV collagenase by tissue kallikrein. J. Cell Physiol. 157: 587-593.
118. Desrochers, P. E., Mookhtiar, K., Van Wart, H. E., Hasty, K. A., and Weiss, S. J. 1992. Proteolytic inactivation of α1-proteinase inhibitor and α1-antichymotrypsin by oxidatively activated human neutrophil metalloproteinases. J. Biol. Chem. 267: 5005-5012.
119. de Waal, M. R., Figdor, C. G., Huijbens, R., Mohan, P. S., Bennett, B., Culpepper, J., Dang, W., Zurawski, G., and de Vries, J. E. 1993. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J. Immunol. 151: 6370-6381.
120. D'Haese, A., Wuyts, A., Dillen, C., Dubois, B., Billiau, A., Heremans, H., Van Damme, J., Arnold, B., and Opdenakker, G. 2000. In vivo neutrophil recruitment by granulocyte chemotactic protein-2 is assisted by gelatinase B/MMP-9 in the mouse. J. Interferon Cytokine Res. 20: 667-674.
121. Dhawan, S., Toro, L. A., Jones, B. E., and Meltzer, M. S. 1992. Interactions between HIV-infected monocytes and the extracellular matrix: HIV-infected monocytes secrete neutral metalloproteases that degrade basement membrane protein matrices. J. Leukoc. Biol. 52: 244-248.
122. Dhawan, S., Weeks, B. S., Soderland, C., Schnaper, H. W., Toro, L. A., Asthana, S. P., Hewlett, I. K., Stetler-Stevenson, W. G., Yamada, S. S., and Yamada, K. M. 1995. HIV-1 infection alters monocyte interactions with human microvascular endothelial cells. J. Immunol. 154: 422-432.
123. DiPersio, C. M., Shao, M., Di Costanzo, L., Kreidberg, J. A., and Hynes, R. O. 2000. Mouse keratinocytes immortalized with large T antigen acquire alpha3beta1 integrin-dependent secretion of MMP-9/gelatinase B. J. Cell Sci. 113: 2909-2921.
124. Docherty, A. J., Lyons, A., Smith, B. J., Wright, E. M., Stephens, P. E., Harris, T. J., Murphy, G., and Reynolds, J. J. 1985. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 318: 66-69.
125. Dong, Z., Nemeth, J. A., Cher, M. L., Palmer, K. C., Bright, R. C., and Fridman, R. 2001. Differential regulation of matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 (TIMP-1) and TIMP-2 expression in co-cultures of prostate cancer and stromal cells. Int. J. Cancer 93: 507-515.
126. D'Ortho, M. P., Jarreau, P. H., Delacourt, C., Pezet, S., Lafuma, C., Harf, A., and Macquin-Mavier, I. 1995. Tachykinins induce gelatinase production by guinea pig alveolar macrophages: involvement of NK2 receptors. Am. J. Physiol. 269: L631-L636.
127. Dreier, R., Wallace, S., Fuchs, S., Bruckner, P., and Grassel, S. 2001. Paracrine interactions of chondrocytes and macrophages in cartilage degradation: articular chondrocytes provide factors that activate macrophage-derived progelatinase B (pro-MMP-9). J. Cell Sci. 114: 3813-3822.
128. Dubois, B., Peumans, W. J., Van Damme, E., Van Damme, J., and Opdenakker, G. 1998. Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins. FEBS Lett. 427: 275-278.
129. Dubois, B., Masure, S., Hurtenbach, U., Paemen, L., Heremans, H., van den Oord, J., Sciot, R., Meinhardt, T., Hämmerling, G., Opdenakker, G., and Arnold, B. 1999. Resistance of young gelatinase B-deficient mice to experimental autoimmune encephalomyelitis and necrotizing tail lesions. J. Clin. Invest. 104: 1507-1515.
130. Dubois, B., Arnold, B., and Opdenakker, G. 2000. Gelatinase B deficiency impairs reproduction. J. Clin. Invest. 106: 627-628.
131. Dubois, B., Starckx, S., Pagenstecher, A., van den Oord, J., Arnold, B., and Opdenakker, G. 2002. Gelatinase B deficiency protects against endotoxin shock. Eur. J. Immunol. 32: 2163-2171.
132. Duivenvoorden, W. C., Hirte, H. W., and Singh, G. 1999. Transforming growth factor beta1 acts as an inducer of matrix metalloproteinase expression and activity in human bone-metastasizing cancer cells. Clin. Exp. Metastasis 17: 27-34
133. Duncan, M. E., Richardson, J. P., Murray, G. I., Melvin, W. T., and Fothergill, J. E. 1998. Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form. Eur. J. Biochem. 258: 37-43.
134. Dunsmore, S. E., Rubin, J. S., Kovacs, S. O., Chedid, M., Parks, W. C., and Welgus, H. G. 1996. Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production. J. Biol. Chem. 271: 24576-24582.
135. Eberhardt, W., Beeg, T., Beck, K. F., Walpen, S., Gauer, S., Bohles, H., and Pfeilschifter, J. 2000a. Nitric oxide modulates expression of matrix metalloproteinase-9 in rat mesangial cells. Kidney Int. 57: 59-69.
136. Eberhardt, W., Huwiler, A., Beck, K. F., Walpen, S., and Pfeilschifter, J. 2000b. Amplification of IL-1 beta-induced matrix metalloproteinase-9 expression by superoxide in rat glomerular mesangial cells is mediated by increased activities of NF-kappa B and activating protein-1 and involves activation of the mitogen-activated protein kinase pathways. J. Immunol. 165: 5788-5797.
137. Eccles, S. A., Box, G. M., Court, W. J., Bone, E. A., Thomas, W., and Brown, P. D. 1996. Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). Cancer Res. 56: 2815-2822.
138. Edvardsen, K., Chen, W., Rucklidge, G., Walsh, F. S., Obrink, B., and Bock, E. 1993. Transmembrane neural cell-adhesion molecule (NCAM), but not glycosyl-phosphatidylinositol-anchored NCAM, down-regulates secretion of matrix metalloproteinases. Proc. Natl. Acad. Sci. U. S. A. 90: 11463-11467.
139. Eeckhout, Y. and Vaes, G. 1977. Further studies on the activation of procollagenase, the latent precursor of bone collagenase. Effects of lysosomal cathepsin B, plasmin and kallikrein, and spontaneous activation. Biochem. J. 166: 21-31.
140. Egeblad, M. and Werb, Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nature Rev. Cancer 2: 161-174.
141. Elkins, P. A., Ho, Y. S., Smith, W. W., Janson, C. A., D'Alessio, K. J., McQueney, M. S., Cummings, M. D., and Romanic, A. M. 2002. Structure of the C-terminally truncated human ProMMP9, a gelatin-binding matrix metalloproteinase. Acta Crystallogr. D. Biol. Crystallogr. 58: 1182-1192.
142. Ellerbroek, S. M., Fishman, D. A., Kearns, A. S., Bafetti, L. M., and Stack, M. S. 1999. Ovarian carcinoma regulation of matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase through beta1 integrin. Cancer Res. 59: 1635-1641.
143. Ellerbroek, S. M., Halbleib, J. M., Benavidez, M., Warmka, J. K., Wattenberg, E. V., Stack, M. S., and Hudson, L. G. 2001a. Phosphatidylinositol 3-kinase activity in epidermal growth factor-stimulated matrix metalloproteinase-9 production and cell surface association. Cancer Res. 61: 1855-1861.
144. Ellerbroek, S. M., Wu, Y. I., Overall, C. M., and Stack, M. S. 2001b. Functional interplay between type I collagen and cell surface matrix metalloproteinase activity. J. Biol. Chem. 276: 24833-24842.
145. Emonard, H. and Hornebeck, W. 1997. Binding of 92 kDa and 72 kDa progelatinases to insoluble elastin modulates their proteolytic activation. Biol. Chem. 378: 265-271.
146. Endo, S., Inada, K., Ceska, M., Takakuwa, T., Yamada, Y., Nakae, H., Kasai, T., Yamashita, H., Taki, K., and Yoshida, M. 1995. Plasma interleukin 8 and polymorphonuclear leukocyte elastase concentrations in patients with septic shock. J. Inflamm. 45: 136-142.
147. Engsig, M. T., Chen, Q. J., Vu, T. H., Pedersen, A. C., Therkidsen, B., Lund, L. R., Henriksen, K., Lenhard, T., Foged, N. T., Werb, Z., and Delaisse, J. M. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J. Cell Biol. 151: 879-889.
148. Esparza, J., Vilardell, C., Calvo, J., Juan, M., Vives, J., Urbano-Marquez, A., Yague, J., and Cid, M. C. 1999. Fibronectin upregulates gelatinase B (MMP-9) and induces coordinated expression of gelatinase A (MMP-2) and its activator MT1-MMP (MMP-14) by human T lymphocyte cell lines. A process repressed through RAS/MAP kinase signaling pathways. Blood 94: 2754-2766.
149. Estève, P. O., Tremblay, P., Houde, M., St Pierre, Y., and Mandeville, R. 1998. In vitro expression of MMP-2 and MMP-9 in glioma cells following exposure to inflammatory mediators. Biochim. Biophys. Acta 1403: 85-96.
150. Everts, V., Delaissé, J. -M., Korper, W., Niehof, A., Vaes, G., and Beertsen, W. 1992. Degradation of collagen in the bone-resorbing compartment underlying the osteoclast involves both cysteine-proteinases and matrix metalloproteinases. J. Cell Physiol. 150: 221-231.
151. Fabra, A., Nakajima, M., Bucana, C. D., and Fidler, I. J. 1992. Modulation of the invasive phenotype of human colon carcinoma cells by organ specific fibroblasts of nude mice. Differentiation 52: 101-110.
152. Faller, D. V., Weng, H., and Choi, S. Y. 1997. Activation of collagenase IV gene expression and enzymatic activity by the Moloney murine leukemia virus long terminal repeat. Virology 227: 331-342.
153. Fan, W. H. and Karnovsky, M. J. 2002. Increased MMP-2 expression in connective tissue growth factor over-expression vascular smooth muscle cells. J. Biol. Chem. 277: 9800-9805.
154. Fang, K. C., Raymond, W. W., Lazarus, S. C., and Caughey, G. H. 1996. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J. Clin. Invest. 97: 1589-1596.
155. Farina, A. R., Tacconelli, A., Vacca, A., Maroder, M., Gulino, A., and Mackay, A. R. 1999. Transcriptional up-regulation of matrix metalloproteinase-9 expression during spontaneous epithelial to neuroblast phenotype conversion by SK-N-SH neuroblastoma cells, involved in enhanced invasivity, depends upon GT-box and nuclear factor kappaB elements. Cell Growth Differ. 10: 353-367.
156. Fernandez-Patron, C., Zouki, C., Whittal, R., Chan, J. S., Davidge, S. T., and Filep, J. G. 2001. Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]. FASEB J. 15: 2230-2240.
157. Ferrand, P. E., Parry, S., Sammel, M., Macones, G. A., Kuivaniemi, H., Romero, R., and Strauss, J. F., 2002. A polymorphism in the matrix metalloproteinase-9 promoter is associated with increased risk of preterm premature rupture of membranes in African-Americans. Mol. Hum. Reprod. 8: 494-501.
158. Ferry, G., Lonchampt, M., Pennel, L., de Nanteuil, G., Canet, E., and Tucker, G. C. 1997. Activation of MMP-9 by neutrophil elastase in an in vivo model of acute lung injury. FEBS Lett. 402: 111-115.
159. Fibbe, W. E., Pruijt, J. F. M., Velders, G. A., Opdenakker, G., van Kooyk, Y., Figdor, C. G., and Willemze, R. 1999. Biology of IL-8-induced stem cell mobilization. Ann. N. Y. Acad. Sci. 872: 71-82.
160. Fiorino, A. S. and Zvibel, I. 1996. Disruption of cell-cell adhesion in the presence of sodium butyrate activates expression of the 92 kDa type IV collagenase in MDCK cells. Cell Biol. Int. 20: 489-499.
161. Fisher, C., Gilbertson, B. S., Powers, E. A., Petzold, G., Poorman, R., and Mitchell, M. A. 1994. Interstitial collagenase is required for angiogenesis in vitro. Dev. Biol. 162: 499-510.
162. Fisher, G. J., Datta, S. C., Talwar, H. S., Wang, Z. Q., Varani, J., Kang, S., and Voorhees, J. J. 1996. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 379: 335-339.
163. Fisher, G. J., Wang, Z. Q., Datta, S. C., Varani, J., Kang, S., and Voorhees, J. J. 1997. Pathophysiology of premature skin aging induced by ultraviolet light. N. Engl. J. Med. 337: 1419-1428.
164. Fisher, S. J., Cui, T.-Y., Zhang, L., Hartman, L., Grahl, K., Zhang, G. -Y., Tarpey, J., and Damsky, C. H. 1989. Adhesive and degradative properties of human placental cytotrophoblast cells in vitro. J. Cell Biol. 109: 891-902.
165. Fishman, D. A., Kearns, A., Chilukuri, K., Bafetti, L. M., O'Toole, E. A., Georgacopoulos, J., Ravosa, M. J., and Stack, M. S. 1998. Metastatic dissemination of human ovarian epithelial carcinoma is promoted by alpha2beta1-integrin-mediated interaction with type I collagen. Invasion Metastasis 18: 15-26.
166. Foda, H. D., George, S., Conner, C., Drews, M., Tompkins, D. C., and Zucker, S. 1996. Activation of human umbilical vein endothelial cell progelatinase A by phorbol myristate acetate: a protein kinase C-dependent mechanism involving a membrane-type matrix metalloproteinase. Lab. Invest. 74: 538-545.
167. Forsyth, P. A., Wong, H., Laing, T. D., Newcastle, N. B., Morris, D. G., Muzik, H., Leco, K. J., Johnston, R. N., Brasher, P. M. A., Sutherland, G., and Edwards, D. R. 1999. Gelatinase-A (MMP-2), gelatinase-B (MMP-9) and membrane type matrix metalloproteinase-1 (MT1-MMP) are involved in different aspects of the pathophysiology of malignant gliomas. Br. J. Cancer 79: 1828-1835.
168. Fosang, A. J., Neame, P. J., Last, K., Hardingham, T. E., Murphy, G., and Hamilton, J. A. 1992. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B. J. Biol. Chem. 267: 19470-19474.
169. Freestone, T., Turner, R. J., Coady, A., Higman, D. J., Greenhalgh, R. M., and Powell, J. T. 1995. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 15: 1145-1151.
170. Fridman, R., Lacal, J. C., Reich, R., Bonfil, D. R., and Ahn, C. H. 1990. Differential effects of phorbol ester on the in vitro invasiveness of malignant and non-malignant human fibroblast cells. J. Cell Physiol. 142: 55-60.
171. Fridman, R., Toth, M., Pena, D., and Mobashery, S. 1995. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res. 55: 2548-2555.
172. Friedberg, M. H., Glantz, M. J., Klempner, M. S., Cole, B. F., and Perides, G. 1998. Specific matrix metalloproteinase profiles in the cerebrospinal fluid correlated with the presence of malignant astrocytomas, brain metastases, and carcinomatous meningitis. Cancer 82: 923-930.
173. Frisch, S. M. and Morisaki, J. H. 1990. Positive and negative transcriptional elements of the human type IV collagenase gene. Mol. Cell Biol. 10: 6524-6532.
174. Frisch, S. M., Reich, R., Collier, I. E., Genrich, L. T., Martin, G., and Goldberg, G. I. 1990. Adenovirus E1A represses protease gene expression and inhibits metastasis of human tumor cells. Oncogene 5: 75-83.
175. Fukui, N., McAlinden, A., Zhu, Y., Crouch, E., Broekelmann, T. J., Mecham, R. P., and Sandell, L. J. 2002. Processing of type II procollagen amino propeptide by matrix metalloproteinases. J. Biol. Chem. 277: 2193-201.
176. Galboiz, Y., Shapiro, S., Lahat, N., Rawashdeh, H., and Miller, A. 2001. Matrix metalloproteinases and their tissue inhibitors as markers of disease subtype and response to interferon-beta therapy in relapsing and secondary-progressive multiple sclerosis patients. Ann. Neurol. 50: 443-451.
177. Galis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E., Unemori, E. N., Lark, M. W., Amento, E., and Libby, P. 1994a. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75: 181-189.
178. Galis, Z. S., Sukhova, G. K., Lark, M. W., and Libby, P. 1994b. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94: 2493-2503.
179. Galis, Z. S., Sukhova, G. K., and Libby, P. 1995. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J. 9: 974-980.
180. Galis, Z. S., Asanuma, K., Godin, D., and Meng, X. 1998. N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy? Circulation 97: 2445-2453.
181. Galt, S. W., Lindemann, S., Medd, D., Allen, L. L., Kraiss, L. W., Harris, E. S., Prescott, S. M., McIntyre, T. M., Weyrich, A. S., and Zimmerman, G. A. 2001. Differential regulation of matrix metalloproteinase-9 by monocytes adherent to collagen and platelets. Circ. Res. 89: 509-516.
182. Garbisa, S., Pozzatti, R., Muschel, R. J., Saffiotti, U., Ballin, M., Goldfarb, R. H., Khoury, G., and Liotta, L. A. 1987. Secretion of type IV collagenolytic protease and metastatic phenotype: induction by transfection with c-Ha-ras but not c-Ha-ras plus Ad2-E1a. Cancer Res. 47: 1523-1528.
183. Gasche, Y., Fujimura, M., Morita-Fujimura, Y., Copin, J. -C., Kawase, M., Massengale, J., and Chan, P. H. 1999. Early appearance of activated matrix metalloproteinase-9 after focal cerebral ischemia in mice: a possible role in blood-brain barrier dysfunction. J. Cereb. Blood Flow Metab. 19: 1020-1028.
184. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. 1994. Processing of tumour necrosis factor-α precursor by metalloproteinases. Nature 370: 555-557.
185. Genersch, E., Hayess, K., Neuenfeld, Y., and Haller, H. 2000. Sustained ERK phosphorylation is necessary but not sufficient for MMP-9 regulation in endothelial cells: involvement of Ras-dependent and-independent pathways. J. Cell Sci. 113: 4319-4330.
186. George, H. J., Marchand, P., Murphy, K., Wiswall, B. H., Dowling, R., Giannaras, J., Hollis, G. F., Trzaskos, J. M., and Copeland, R. A. 1997. Recombinant human 92-kDa type IV collagenase/gelatinase from baculovirus-infected insect cells: expression, purification, and characterization. Protein Exp. Purif. 10: 154-161.
187. Gerber, H. -P., Vu, T. H., Ryan, A. M., Kowalski, J., Werb, Z., and Ferrara, N. 1999. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation. Nat. Med. 5: 623-628.
188. Ghosh, S. K. and Faller, D. V. 1999. Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1. J. Virol. 73: 4931-4940.
189. Giannelli, G., Bergamini, C., Fransvea, E., Marinosci, F., Quaranta, V., and Antonaci, S. 2001. Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab. Invest. 81: 613-627.
190. Gijbels, K., Galardy, R. E., and Steinman, L. 1994. Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases. J. Clin. Invest. 94: 2177-2182.
191. Gijbels, K., Masure, S., Carton, H., and Opdenakker, G. 1992. Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders. J. Neuroimmunol. 41: 29-34.
192. Gijbels, K., Proost, P., Masure, S., Carton, H., Billiau, A., and Opdenakker, G. 1993. Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein. J. Neurosci. Res. 36: 432-440.
193. Giraudon, P., Thomasset, N., Bernard, A., Verrier, B., and Belin, M. F. 1995. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I. Eur. J. Neurosci. 7: 841-848.
194. Giraudon, P., Buart, S., Bernard, A., and Belin, M. F. 1997. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): possible involvement in neurodegenerative processes. Mol. Psychiatry 2: 107-112.
195. Giraudon, P., Vernant, J. C., Confavreux, C., Belin, M. F., and Desgranges, C. 1998. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology 50: 1920.
196. Gohji, K., Fidler, I. J., Tsan, R., Radinsky, R., von Eschenbach, A. C., Tsuruo, T., and Nakajima, M. 1994a. Human recombinant interferons-beta and -gamma decrease gelatinase production and invasion by human KG-2 renal-carcinoma cells. Int. J. Cancer 58: 380-384.
197. Gohji, K., Nakajima, M., Fabra, A., Bucana, C. D., von Eschenbach, A. C., Tsuruo, T., and Fidler, I. J. 1994b. Regulation of gelatinase production in metastatic renal cell carcinoma by organ-specific fibroblasts. Jpn. J. Cancer Res. 85: 152-160.
198. Goldberg, G. I., Frisch, S. M., He, C., Wilhelm, S. M., Reich, R., and Collier, I. E. 1990. Secreted proteases. Regulation of their activity and their possible role in metastasis. Ann. N. Y. Acad. Sci. 580: 375-384.
199. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Marmer, B. L. 1992. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin. J. Biol. Chem. 267: 4583-4591.
200. Gomez, D. E., Alonso, D. F., Yoshiji, H., and Thorgeirsson, U. P. 1997. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur. J. Cell Biol. 74: 111-122.
201. Granelli-Piperno, A. and Reich, E. 1978. A study of proteases and protease-inhibitor complexes in biological fluids. J. Exp. Med. 148: 223-234.
202. Graesser, D., Mahooti, S., Haas, T., Davis, S., Clark, R. B., and Madri, J. A. 1998. The interrelationship of alpha4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis. Lab. Invest. 78: 1445-1458.
203. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. 1997. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol. 150: 1571-1582.
204. Gress, T. M., Müller-Pillasch, F., Lerch, M. M., Friess, H., Büchler, M., and Adler, G. 1995. Expression and in-situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer 62: 407-413.
205. Grigorova-Borsos, A. M., Bakillah, A., Urios, P., Leblond, V., Guillot, R., and Sternberg, M. 1996. Production of type IV collagen and 72-kDa gelatinase by human endothelial cells cultured in high glucose. Effects of a protein kinase C inhibitor, GF 109203X. Biochem. Cell Biol. 74: 659-667.
206. Grillet, B., Dequeker, J., Paemen, L., Van Damme, B., and Opdenakker, G. 1997. Gelatinase B in chronic synovitis: immunolocalization with a monoclonal antibody. Br. J. Rheumatol. 36: 744-747.
207. Gruber, B. L., Marchese, M. J., Suzuki, K., Schwartz, L. B., Okada, Y., Nagase, H., and Ramamurthy, N. S. 1989. Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation. J. Clin. Invest. 84: 1657-1662.
208. Gruber, B. L., Sorbi, D., French, D. L., Marchese, M. J., Nuovo, G. J., Kew, R. R., and Arbeit, L. A. 1996. Markedly elevated serum MMP-9 (gelatinase B) levels in rheumatoid arthritis: a potentially useful laboratory marker. Clin. Immunol. Immunopathol. 78: 161-171.
209. Guccione, M., Silbiger, S., Lei, J., and Neugarten, J. 2002. Estradiol upregulates mesangial cell MMP-2 activity via the transcription factor AP-2. Am. J. Physiol. Renal Physiol. 282: F164-F169.
210. Gullberg, U., Andersson, E., Garwicz, D., Lindmark, A., and Olsson, I. 1997. Biosynthesis, processing and sorting of neutrophil proteins: insight into neutrophil granule development. Eur. J. Haematol. 58: 137-153.
211. Gum, R., Lengyel, E., Juarez, J., Chen, J. H., Sato, H., Seiki, M., and Boyd, D. 1996. Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. J. Biol. Chem. 271: 10672-10680.
212. Gum, R., Wang, H., Lengyel, E., Juarez, J., and Boyd, D. 1997. Regulation of 92 kDa type IV collagenase expression by the jun aminoterminal kinase- and the extracellular signal-regulated kinase-dependent signaling cascades. Oncogene 14: 1481-1493.
213. Guo, H., Zucker, S., Gordon, M. K., Toole, B. P., and Biswas, C. 1997. Stimulation of matrix metalloproteinase production by recombinant extracellular matrix metalloproteinase inducer from transfected Chinese hamster ovary cells. J. Biol. Chem. 272: 24-27.
214. Gurjar, M. V., Deleon, J., Sharma, R. V., and Bhalla, R. C. 2001a. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. J. Appl. Physiol. 91: 1380-1386.
215. Gurjar, M. V., Deleon, J., Sharma, R. V., and Bhalla, R. C. 2001b. Role of reactive oxygen species in IL-1 beta-stimulated sustained ERK activation and MMP-9 induction. Am. J. Physiol. Heart Circ. Physiol. 281: H2568-H2574.
216. Gurjar, M. V., Sharma, R. V., and Bhalla, R. C. 1999. eNOS gene transfer inhibits smooth muscle cell migration and MMP-2 and MMP-9 activity. Arterioscler. Thromb. Vasc. Biol. 19: 2871-2877.
217. Gutman, A. and Wasylyk, B. 1990. The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J. 9: 2241-2246.
218. Haas, T. L., Davis, S. J., and Madri, J. A. 1998. Three-dimensional type I collagen lattices induce coordinate expression of matrix metalloproteinases MT1-MMP and MMP-2 in microvascular endothelial cells. J. Biol. Chem. 273: 3604-3610.
219. Hack, C. E., Hart, M., van Schijndel, R. J., Eerenberg, A. J., Nuijens, J. H., Thijs, L. G., and Aarden, L. A. 1992. Interleukin-8 in sepsis: relation to shock and inflammatory mediators. Infect. Immun. 60: 2835-2842.
220. Hägglund, A. C., Ny, A., Leonardsson, G., and Ny, T. 1999. Regulation and localization of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the mouse ovary during gonadotropin-induced ovulation. Endocrinology 140: 4351-4358.
221. Hamdy, F. C., Fadlon, E. J., Cottam, D., Lawry, J., Thurrell, W., Silcocks, P. B., Anderson, J. B., Williams, J. L., and Rees, R. C. 1994. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign prostatic hyperplasia. Br. J. Cancer 69: 177-182.
222. Han, Y. P., Tuan, T. L., Hughes, M., Wu, H., and Garner, W. L. 2001. Transforming growth factor-beta - and tumor necrosis factor-alpha-mediated induction and proteolytic activation of MMP-9 in human skin. J. Biol. Chem. 276: 22341-22350.
223. Hanemaaijer, R., Koolwijk, P., le Clercq, L., de Vree, W. J., and van Hinsbergh, V. W. 1993. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J. 296: 803-809.
224. Hanemaaijer, R., Visser, H., Konttinen, Y. T., Koolwijk, P., and Verheijen, J. H. 1998. A novel and simple immunocapture assay for determination of gelatinase-B (MMP-9) activities in biological fluids: saliva from patients with Sjögren's syndrome contain increased latent and active gelatinase-B levels. Matrix Biol. 17: 657-665.
225. Harendza, S., Pollock, A. S., Mertens, P. R., and Lovett, D. H. 1995. Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells. J. Biol. Chem. 270: 18786-18796.
226. Harris, E. D. and Krane, S. M. 1972. An endopeptidase from rheumatoid synovial tissue culture. Biochim. Biophys. Acta 258: 566-576.
227. Harvey, M. B., Leco, K. J., Arcellana-Panlilio, M. Y., Zhang, X., Edwards, D. R., and Schultz, G. A. 1995. Proteinase expression in early mouse embryos is regulated by leukaemia inhibitory factor and epidermal growth factor. Development 121: 1005-1014.
228. Harvey, P., Clark, I. M., Jaurand, M. C., Warn, R. M., and Edwards, D. R. 2000. Hepatocyte growth factor/scatter factor enhances the invasion of mesothelioma cell lines and the expression of matrix metalloproteinases. Br. J. Cancer 83: 1147-1153.
229. Hasan, S. and Nakajima, M. 1999. Retinoic acid synergizes with cyclic AMP to enhance MMP-2 basal promoter activity. Biochem. Biophys. Res. Commun. 258: 663-667.
230. Hasty, K. A., Pourmotabbed, T. F., Goldberg, G. I., Thompson, J. P., Spinella, D. G., Stevens, R. M., and Mainardi, C. L. 1990. Human neutrophil collagenase. A distinct gene product with homology to other matrix metalloproteinases. J. Biol. Chem. 265: 11421-11424.
231. Hauck, C. R., Sieg, D. J., Hsia, D. A., Loftus, J. C., Gaarde, W. A., Monia, B. P., and Schlaepfer, D. D. 2001. Inhibition of focal adhesion kinase expression or activity disrupts epidermal growth factor-stimulated signaling promoting the migration of invasive human carcinoma cells. Cancer Res. 61: 7079-7090.
232. Hayakawa, T., Yamashita, K., Tanzawa, K., Uchijima, E., and Iwata, K. 1992. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett. 298: 29-32.
233. Hazan, R. B., Phillips, G. R., Qiao, R. F., Norton, L., and Aaronson, S. A. 2000. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J. Cell Biol. 148: 779-790.
234. He, C. 1996. Molecular mechanism of transcriptional activation of human gelatinase B by proximal promoter. Cancer Lett. 106: 185-191.
235. Hecker-Kia, A., Kolkenbrock, H., Orgel, D., Zimmermann, B., Sparmann, M., and Ulbrich, N. 1997. Substance P induces the secretion of gelatinase A from human synovial fibroblasts. Eur. J. Clin. Chem. Clin. Biochem. 35: 655-660.
236. Hedlund, M., Karlsson, A., Dahlgren, C., and Leffler, H. 2001. Galectin-3 binds to gelatinase B and lactoferrin from human neutrophil leukocytes. Glycoconj. J. 18: 99.
237. Heissig, B., Hattori, K., Dias, S., Friedrich, M., Ferris, B., Hackett, N. R., Crystal, R. G., Besmer, P., Lyden, D., Moore, M. A., Werb, Z., and Rafii, S. 2002. Recruitment of stem and progenitor cells from the bone marrow niche requires mmp-9 mediated release of kit-ligand. Cell 109: 625-637.
238. Heo, J. H., Lucero, J., Abumiya, T., Koziol, J. A., Copeland, B. R., and del Zoppo GJ 1999. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J. Cereb. Blood Flow Metab. 19: 624-633.
239. Heussen, C. and Dowdle, E. B. 1980. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem. 102: 196-202.
240. Hewson, A. K., Smith, T., Leonard, J. P., and Cuzner, M. L. 1995. Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790. Inflamm. Res. 44: 345-349.
241. Heymans, S., Luttun, A., Nuyens, D., Theilmeier, G., Creemers, E., Moons, L., Dyspersin, G. D., Cleutjens, J. P., Shipley, M., Angellilo, A., Levi, M., Nübe, O., Baker, A., Keshet, E., Lupu, F., Herbert, J.-M., Smits, J. F., Shapiro, S. D., Baes, M., Borgers, M., Collen, D., Daemen, M. J., and Carmeliet, P. 1999. Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat. Med. 5: 1135-1142.
242. Hibbs, M. S., Hoidal, J. R., and Kang, A. H. 1987. Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages. J. Clin. Invest. 80: 1644-1650.
243. Higashino, F., Yoshida, K., Noumi, T., Seiki, M., and Fujinaga, K. 1995. Ets-related protein E1A-F can activate three different matrix metalloproteinase gene promoters. Oncogene 10: 1461-1463.
244. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W., and Muschel, R. J. 1994. Metalloproteinases in tumor progression: the contribution of MMP-9. Invasion Metastasis 14: 246-258.
245. Himelstein, B. P., Lee, E. J., Sato, H., Seiki, M., and Muschel, R. J. 1997. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line. Oncogene 14: 1995-1998.
246. Himelstein, B. P. and Koch, C. J. 1998. Studies of type IV collagenase regulation by hypoxia. Cancer Lett. 124: 127-133.
247. Himelstein, B. P., Lee, E. J., Sato, H., Seiki, M., and Muschel, R. J. 1998. Tumor cell contact mediated transcriptional activation of the fibroblast matrix metalloproteinase-9 gene: involvement of multiple transcription factors including Ets and an alternating purine-pyrimidine repeat. Clin. Exp. Metastasis 16: 169-177.
248. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R., and Weiss, S. J. 1998. Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95: 365-377.
249. Hirose, T., Reife, R. A., Smith GN, Stevens, R. M., Mainardi, C. L., and Hasty, K. A. 1992. Characterization of type V collagenase (gelatinase) in synovial fluid of patients with inflammatory arthritis. J. Rheumatol. 19: 593-599.
250. Hoeben, E., Van Aelst, I., Swinnen, J. V., Opdenakker, G., and Verhoeven, G. 1996. Gelatinase A secretion and its control in peritubular and Sertoli cell cultures: effects of hormones, second messengers and inducers of cytokine production. Mol. Cell Endocrinol. 118: 37-46.
251. Hofmann, A., Laue, S., Rost, A. K., Scherbaum, W. A., and Aust, G. 1998. mRNA levels of membrane-type 1 matrix metalloproteinase (MT1-MMP), MMP-2, and MMP-9 and of their inhibitors TIMP-2 and TIMP-3 in normal thyrocytes and thyroid carcinoma cell lines. Thyroid 8: 203-214.
252. Hofmann, U. B., Westphal, J. R., Van Kraats, A. A., Ruiter, D. J., and Van Muijen, G. N. 2000. Expression of integrin alpha(v)beta(3) correlates with activation of membrane-type matrix metalloproteinase-1 (MT1-MMP) and matrix metalloproteinase-2 (MMP-2) in human melanoma cells in vitro and in vivo. Int. J. Cancer 87: 12-19.
253. Hoshino, M., Takahashi, M., Takai, Y., and Sim, J. 1999. Inhaled corticosteroids decrease subepithelial collagen deposition by modulation of the balance between matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 expression in asthma. J. Allergy Clin. Immunol. 104: 356-363.
254. Hou, G., Mulholland, D., Gronska, M. A., and Bendeck, M. P. 2000. Type VIII collagen stimulates smooth muscle cell migration and matrix metalloproteinase synthesis after arterial injury. Am. J. Pathol. 156: 467-476.
255. Houde, M., de Bruyne, G., Bracke, M., Ingelman-Sundberg, M., Skoglund, G., Masure, S., Van Damme, J., and Opdenakker, G. 1993. Differential regulation of gelatinase B and tissue-type plasminogen activator expression in human Bowes melanoma cells. Int. J. Cancer 53: 395-400.
256. Houde, M., Tremblay, P., Masure, S., Opdenakker, G., Oth, D., and Mandeville, R. 1996. Synergistic and selective stimulation of gelatinase B production in macrophages by lipopolysaccharide, transretinoic acid and CGP 41251, a protein kinase C regulator. Biochim. Biophys. Acta 1310: 193-200.
257. Howard, E. W., Bullen, E. C., and Banda, M. J. 1991. Regulation of the autoactivation of human 72-kDa progelatinase by tissue inhibitor of metalloproteinases-2. J. Biol. Chem. 266: 13064-13069.
258. Hozumi, A., Nishimura, Y., Nishiuma, T., Kotani, Y., and Yokoyama, M. 2001. Induction of MMP-9 in normal human bronchial epithelial cells by TNF-alpha via NF-kappa B-mediated pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 281: L1444-L1452.
259. Huang, Y. T., Hwang, J. J., Lee, P. P., Ke, F. C., Huang, J. H., Huang, C. J., Kandaswami, C., Middleton, E., Jr, and Lee, M. T. 1999. Effects of luteolin and quercetin, inhibitors of tyrosine kinase, on cell growth and metastasis-associated properties in A431 cells overexpressing epidermal growth factor receptor. Br. J. Pharmacol. 128: 999-1010.
260. Hughes, P. M., Wells, G. M., Clements, J. M., Gearing, A. J., Redford, E. J., Davies, M., Smith, K. J., Hughes, R. A., Brown, M. C., and Miller, K. M. 1998. Matrix metalloproteinase expression during experimental autoimmune neuritis. Brain 121: 481-494.
261. Huhtala, P., Chow, L. T., and Tryggvason, K. 1990a. Structure of the human type IV collagenase gene. J. Biol. Chem. 265: 11077-11082.
262. Huhtala, P., Eddy, R. L., Fan, Y. S., Byers, M. G., Shows, T. B., and Tryggvason, K. 1990b. Completion of the primary structure of the human type IV collagenase preproenzyme and assignment of the gene (CLG4) to the q21 region of chromosome 16. Genomics 6: 554-559.
263. Huhtala, P., Humphries, M. J., McCarthy, J. B., Tremble, P. M., Werb, Z., and Damsky, C. H. 1995. Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J. Cell Biol. 129: 867-879.
264. Huhtala, P., Tuuttila, A., Chow, L. T., Lohi, J., Keski, O. J., and Tryggvason, K. 1991. Complete structure of the human gene for 92-kDa type IV collagenase. Divergent regulation of expression for the 92- and 72-kilodalton enzyme genes in HT-1080 cells. J. Biol. Chem. 266: 16485-16490.
265. Hujanen, E. S., Vaisanen, A., Zheng, A., Tryggvason, K., and Turpeenniemi, H. T. 1994. Modulation of M(r) 72,000 and M(r) 92,000 type-IV collagenase (gelatinase A and B) gene expression by interferons alpha and gamma in human melanoma. Int. J. Cancer 58: 582-586.
266. Hummel, V., Kallmann, B. A., Wagner, S., Fuller, T., Bayas, A., Tonn, J. C., Benveniste, E. N., Toyka, K. V., and Rieckmann, P. 2001. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J. Neuropathol. Exp. Neurol. 60: 320-327.
267. Ikebe, T., Takeuchi, H., Jimi, E., Beppu, M., Shinohara, M., and Shirasuna, K. 1998. Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int. J. Cancer 77: 578-585
268. Imagawa, M., Chiu, R., and Karin, M. 1987. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell 51: 251-260.
269. Imai, K., Yokohama, Y., Nakanishi, I., Ohuchi, E., Fujii, Y., Nakai, N., and Okada, Y. 1995. Matrix metalloproteinase 7 (matrilysin) from human rectal carcinoma cells. Activation of the precursor, interaction with other matrix metalloproteinases and enzymic properties. J. Biol. Chem. 270: 6691-6697.
270. Imper, V. and Van Wart, H. E. 1998. Substrate specificity and mechanisms of substrate recognition of the matrix metalloproteinases. In Matrix Metalloproteases (Parks, W. C. and Mecham, R. P., eds) pp. 219-242, Academic, St Louis, MS.
271. Inuzuka, T., Sato, S., Baba, H., and Miyatake, T. 1988. Suppressive effect of camostat mesilate (FOY 305) on acute experimental allergic encephalomyelitis (EAE). Neurochem. Res. 13: 225-228.
272. Ishiwa, J., Sato, T., Mimaki, Y., Sashida, Y., Yano, M., and Ito, A. 2000. A citrus flavonoid, nobiletin, suppresses production and gene expression of matrix metalloproteinase 9/gelatinase B in rabbit synovial fibroblasts. J. Rheumatol. 27: 20-25.
273. Ismair, M. G., Ries, C., Lottspeich, F., Zang, C., Kolb, H. J., and Petrides, P. E. 1998. Autocrine regulation of matrix metalloproteinase-9 gene expression and secretion by tumor necrosis factor-alpha (TNF-alpha) in NB4 leukemic cells: specific involvement of TNF receptor type 1. Leukemia 12: 1136-1143.
274. Itoh, T., Tanioka, M., Matsuda, H., Nishimoto, H., Yoshioka, T., Suzuki, R., and Uehira, M. 1999a. Experimental metastasis is suppressed in MMP-9-deficient mice. Clin. Exp. Metastasis 17: 177-181.
275. Itoh, T., Tanioka, M., Yoshida, H., Yoshioka, T., Nishimoto, H., and Itohara, S. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res. 58: 1048-1051.
276. Itoh, Y., Kajita, M., Kinoh, H., Mori, H., Okada, A., and Seiki, M. 1999b. Membrane type 4 matrix metalloproteinase (MT4-MMP, MMP-17) is a glycosylphosphatidylinositol-anchored proteinase. J. Biol. Chem. 274: 34260-34266.
277. Iurlaro, M., Loverro, G., Vacca, A., Cormio, G., Ribatti, D., Minischetti, M., Ria, R., Bruno, M., and Selvaggi, L. 1999. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur. J. Clin. Invest. 29: 793-801.
278. Janji, B., Melchior, C., Gouon, V., Vallar, L., and Kieffer, N. 1999. Autocrine TGF-beta-regulated expression of adhesion receptors and
279. Janowska-Wieczorek, A., Marquez, L. A., Dobrowsky, A., Ratajczak, M. Z., and Cabuhat, M. L. 2000. Differential MMP and TIMP production by human marrow and peripheral blood CD34(+) cells in response to chemokines. Exp. Hematol. 28: 1274-1285.
280. Janowska-Wieczorek, A., Marquez, L. A., Nabholtz, J. M., Cabuhat, M. L., Montano, J., Chang, H., Rozmus, J., Russell, J. A., Edwards, D. R., and Turner, A. R. 1999. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood 93: 3379-3390.
281. Jeziorska, M., Nagase, H., Salamonsen, L. A., and Woolley, D. E. 1996. Immunolocalization of the matrix metalloproteinases gelatinase B and stromelysin 1 in human endometrium throughout the menstrual cycle. J. Reprod. Fertil. 107: 43-51.
282. Jiang, Y. and Muschel, R. J. 2002. Regulation of matrix metalloproteinase-9 (MMP-9) by translational efficiency in murine prostate carcinoma cells. Cancer Res. 62: 1910-1914.
283. Jiang, Y., Xu, W., Lu, J., He, F., and Yang, X. 2001. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem. Biophys. Res. Commun. 286: 1123-1130.
284. Jin, G., Sah, R. L., Li, Y. S., Lotz, M., Shyy, J. Y., and Chien, S. 2000. Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J. Orthop. Res. 18: 899-908.
285. Jochum, M., Duswald, K. -H., Neumann, S., Witte, J., and Fritz, H. 1984. Proteinases and their inhibitors in septicemia - basic concepts and clinical implications. Adv. Exp. Med. Biol. 167: 391-404.
286. Johansson, N., Ala-aho, R., Uitto, V., Grenman, R., Fusenig, N. E., Lopez-Otin, C., and Kahari, V. M. 2000. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J. Cell Sci. 113: 227-235.
287. Johnatty, R. N., Taub, D. D., Reeder, S. P., Turcovski, C. S., Cottam, D. W., Stephenson, T. J., and Rees, R. C. 1997. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158: 2327-2333.
288. Jovanovic, D. V., Martel-Pelletier, J., Di Battista, J. A., Mineau, F., Jolicoeur, F. C., Benderdour, M., and Pelletier, J. P. 2000. Stimulation of 92-kd gelatinase (matrix metalloproteinase 9) production by interleukin-17 in human monocyte/macrophages: a possible role in rheumatoid arthritis. Arthritis Rheum. 43: 1134-1144.
289. Juarez, J., Clayman, G., Nakajima, M., Tanabe, K. K., Saya, H., Nicolson, G. L., and Boyd, D. 1993. Role and regulation of expression of 92-kDa type-IV collagenase (MMP-9) in two invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer 55: 10-18.
290. Juliano, R. L. 2002. Signal transduction by cell adhesion receptors and the cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu. Rev. Pharmacol. Toxicol. 42: 283-323.
291. Kambara, C., Nakamura, T., Furuya, T., Migita, K., Ida, H., Kawakami, A., Shirabe, S., Nakane, S., Kinoshita, I., and Eguchi, K. 1999. Vascular cell adhesion molecule-1-mediated matrix metalloproteinase-2 induction in peripheral blood T cells is up-regulated in patients with HTLV-I-associated myelopathy. J. Neuroimmunol. 99: 242-247.
292. Kanemoto, T., Reich, R., Royce, L., Greatorex, D., Adler, S. H., Shiraishi, N., Martin, G. R., Yamada, Y., and Kleinman, H. K. 1990. Identification of an amino acid sequence from the laminin A chain that stimulates metastasis and collagenase IV production. Proc. Natl. Acad. Sci. U. S. A. 87: 2279-2283.
293. Kapila, Y. L., Kapila, S., and Johnson, P. W. 1996. Fibronectin and fibronectin fragments modulate the expression of proteinases and proteinase inhibitors in human periodontal ligament cells. Matrix Biol. 15: 251-261.
294. Karelina, T. V., Hruza, G. J., Goldberg, G. I., and Eisen, A. Z. 1993. Localization of 92-kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. J. Invest. Dermatol. 100: 159-165.
295. Kataoka, H., DeCastro, R., Zucker, S., and Biswas, C. 1993. Tumor cell-derived collagenase-stimulatory factor increases expression of interstitial collagenase, stromelysin, and 72-kDa gelatinase. Cancer Res. 53: 3154-3158.
296. Kato, N., Nawa, A., Tamakoshi, K., Kikkawa, F., Suganuma, N., Okamoto, T., Goto, S., Tomoda, Y., Hamaguchi, M., and Nakajima, M. 1995. Suppression of gelatinase production with decreased invasiveness of choriocarcinoma cells by human recombinant interferon beta. Am. J. Obstet. Gynecol. 172: 601-606.
297. Kato, Y., Nakayama, Y., Umeda, M., and Miyazaki, K. 1992. Induction of 103-kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J. Biol. Chem. 267: 11424-11430.
298. Kawaguchi, S., Kikuchi, K., Ishii, S., Takada, Y., Kobayashi, S., and Uede, T. 1992. VLA-4 molecules on tumor cells initiate an adhesive interaction with VCAM-1 molecules on endothelial cell surface. Jpn. J. Cancer Res. 83: 1304-1316.
299. Kawaguchi, Y., Tanaka, H., Okada, T., Konishi, H., Takahashi, M., Ito, M., and Asai, J. 1996. The effects of ultraviolet A and reactive oxygen species on the mRNA expression of 72-kDa type IV collagenase and its tissue inhibitor in cultured human dermal fibroblasts. Arch. Dermatol. Res. 288: 39-44.
300. Kawashima, A., Nakanishi, I., Tsuchiya, H., Roessner, A., Obata, K., and Okada, Y. 1994. Expression of matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) induced by tumour necrosis factor alpha correlates with metastatic ability in a human osteosarcoma cell line. Virchows Arch. 424: 547-552.
301. Keck, T., Balcom, J. H., Fernandez-del Castillo, C., Antoniu, B. A., and Warshaw, A. L. 2002. Matrix metalloproteinase-9 promotes neutrophil migration and alveolar capillary leakage in pancreatitis-associated lung injury in the rat. Gastroenterology 122: 188-201.
302. Kenagy, R. D., Nikkari, S. T., Welgus, H. G., and Clowes, A. W. 1994. Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kDa gelatinase, and collagenase) in primate arterial smooth muscle cells. J. Clin. Invest. 93: 1987-1993.
303. Kerr, L. D., Miller, D. B., and Matrisian, L. M. 1990. TGF-beta 1 inhibition of transin/stromelysin gene expression is mediated through a Fos binding sequence. Cell 61: 267-278.
304. Khan, K. M. and Falcone, D. J. 1997. Role of laminin in matrix induction of macrophage urokinase-type plasminogen activator and 92-kDa metalloproteinase expression. J. Biol. Chem. 272: 8270-8275.
305. Kieseier, B. C., Clements, J. M., Pischel, H. B., Wells, G. M., Miller, K., Gearing, A. J., and Hartung, H.-P. 1998a. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann. Neurol. 43: 427-434.
306. Kieseier, B. C., Kiefer, R., Clements, J. M., Miller, K., Wells, G. M., Schweitzer, T., Gearing, A. J., and Hartung, H. -P. 1998b. Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. Brain 121: 159-166.
307. Kieseier, B. C., Paul, R., Koedel, U., Seifert, T., Clements, J. M., Gearing, A. J., Pfister, H. -W., and Hartung, H. -P. 1999. Differential expression of matrix metalloproteinases in bacterial meningitis. Brain 122: 1579-1587.
308. Kim, H., and Koh, G. 2000. Lipopolysaccharide activates matrix metalloproteinase-2 in endothelial cells through an NF-kappaB-dependent pathway. Biochem. Biophys. Res. Commun. 269: 401-405.
309. Kinoshita, T., Sato, H., Okada, A., Ohuchi, E., Imai, K., Okada, Y., and Seiki, M. 1998. TIMP-2 promotes activation of progelatinase A by membrane-type 1 matrix metalloproteinase immobilized on agarose beads. J. Biol. Chem. 273: 16098-16103.
310. Kitagawa, S., Yuo, A., Yagisawa, M., Azuma, E., Yoshida, M., Furukawa, Y., Takahashi, M., Masuyama, J., and Takaku, F. 1996. Activation of human monocyte functions by tumor necrosis factor, rapid priming for enhanced release of superoxide and erythrophagocytosis, but no direct triggering of superoxide release. Exp. Hematol. 24: 559-567.
311. Kitahara, M., Ichikawa, M., Kinoshita, T., Shiozawa, S., Shigematsu, H., and Komiyama, A. 2001. Prostacyclin inhibits the production of MMP-9 induced by phorbol ester through protein kinase A activation, but does not affect the production of MMP-2 in human cultured mesangial cells. Kidney Blood Press Res. 24: 18-26.
312. Kjeldsen, L., Bjerrum, O. W., Askaa, J., and Borregaard, N. 1992. Subcellular localization and release of human neutrophil gelatinase, confirming the existence of separate gelatinase-containing granules. Biochem. J. 287: 603-610.
313. Kjeldsen, L., Johnsen, A. H., Sengelov, H., and Borregaard, N. 1993. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J. Biol. Chem. 268: 10425-10432.
314. Kleifeld, O., Van den Steen, P. E., Frenkel, A., Cheng, F., Jiang, H. L., Opdenakker, G., and Sagi, I. 2000. Structural characterization of the catalytic active site in the latent and active natural gelatinase B from human neutrophils. J. Biol. Chem. 275: 34335-34343.
315. Kleiner, D. E. and Stetler-Stevenson, W. G. 1994. Quantitative zymography: detection of picogram quantities of gelatinases. Anal. Biochem. 218: 325-329.
316. Klier, C. M. and Nelson, P. J. 1999. Chemokine-induced extravasation of MonoMac 6 cells: chemotaxis and MMP activity. Ann. N. Y. Acad. Sci. 878: 575-577.
317. Knauper, V., Kramer, S., Reinke, H., and Tschesche, H. 1990. Characterization and activation of procollagenase from human polymorphonuclear leucocytes. N-terminal sequence determination of the proenzyme and various proteolytically activated forms. Eur. J. Biochem. 189: 295-300.
318. Knauper, V., Wilhelm, S. M., Seperack, P. K., DeClerck, Y. A., Langley, K. E., Osthues, A., and Tschesche, H. 1993. Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem. J. 295: 581-586.
319. Knauper, V., Murphy, G., and Tschesche, H. 1996a. Activation of human neutrophil procollagenase by stromelysin 2. Eur. J. Biochem. 235: 187-191.
320. Knauper, V., Will, H., Lopez-Otin, C., Smith, B., Atkinson, S. J., Stanton, H., Hembry, R. M., and Murphy, G. 1996b. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J. Biol. Chem. 271: 17124-17131.
321. Knauper, V., Smith, B., Lopez-Otin, C., and Murphy, G. 1997. Activation of progelatinase B (proMMP-9) by active collagenase-3 (MMP-13). Eur. J. Biochem. 248: 369-373.
322. Knight, C. G., Willenbrock, F., and Murphy, G. 1992. A novel coumarin-labeled peptide for sensitive continuous assays of the matrix metalloproteinases. FEBS Lett. 296: 263-266.
323. Kobayashi, T., Hattori, S., Nagai, Y., Tajima, S., and Nishikawa, T. 1998a. Differential regulation of MMP-2 and MMP-9 gelatinases in cultured human keratinocytes. Dermatology 197: 1-5.
324. Kobayashi, T., Sakuraoka, K., Iwamoto, M., and Kurihara, S. 1998b. A case of anaphylactoid purpura with multiple blister formation: possible pathophysiological role of gelatinase (MMP-9). Dermatology 197: 62-64.
325. Kobayashi, Y., Matsumoto, M., Kotani, M., and Makino, T. 1999. Possible involvement of matrix metalloproteinase-9 in Langerhans cell migration and maturation. J. Immunol. 163: 5989-5993.
326. Kobayashi, T., Kishimoto, J., Ge, Y., Jin, W., Hudson, D. L., Ouahes, N., Ehama, R., Shinkai, H., and Burgeson, R. E. 2001. A novel mechanism of matrix metalloproteinase-9 gene expression implies a role for keratinization. EMBO Rep. 2: 604-608.
327. Koivunen, E., Arap, W., Valtanen, H., Rainisalo, A., Medina, O. P., Heikkilä, P., Kantor, C., Gahmberg, C. G., Salo, T., Konttinen, Y. T., Sorsa, T., Ruoslahti, E., and Pasqualini, R. 1999. Tumor targeting with a selective gelatinase inhibitor. Nat. Biotechnol. 17: 768-774.
328. Kojima, S., Itoh, Y., Matsumoto, S., Masuho, Y., and Seiki, M. 2000. Membrane-type 6 matrix metalloproteinase (MT6-MMP, MMP-25) is the second glycosyl-phosphatidyl inositol (GPI)-anchored MMP. FEBS Lett. 480: 142-146.
329. Kolb, S. A., Lahrtz, F., Paul, R., Leppert, D., Nadal, D., Pfister, H.-W., and Fontana, A. 1998. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J. Neuroimmunol. 84: 143-150.
330. Kolkenbrock, H., Hecker-Kia, A., Orgel, D., Ulbrich, N., and Will, H. 1997. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol. Chem. 378: 71-76.
331. Kondapaka, S. B., Fridman, R., and Reddy, K. B. 1997. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells. Int. J. Cancer 70: 722-726.
332. Konttinen, Y. T., Halinen, S., Hanemaaijer, R., Sorsa, T., Hietanen, J., Ceponis, A., Xu, J.-W., Manthorpe, R., Whittington, J., Larsson, A., Salo, T., Kjeldsen, L., Stenman, U.-H., and Eisen, A. Z. 1998. Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome. Matrix Biol. 17: 335-347.
333. Koolwijk, P., Miltenburg, A. M., van Erck M. G., Oudshoorn, M., Niedbala, M. J., Breedveld, F. C., and van Hinsbergh, V. W. 1995. Activated gelatinase-B (MMP-9) and urokinase-type plasminogen activator in synovial fluids of patients with arthritis. Correlation with clinical and experimental variables of inflammation. J. Rheumatol. 22: 385-393.
334. Korzus, E., Nagase, H., Rydell, R., and Travis, J. 1997. The mitogen-activated protein kinase and JAK-STAT signaling pathways are required for an oncostatin M-responsive element-mediated activation of matrix metalloproteinase 1 gene expression. J. Biol. Chem. 272: 1188-1196.
335. Kosano, H., Okano, T., Katsura, Y., Noritake, M., Kado, S., Matsuoka, T., and Nishigori, H. 1999. ProMMP-9 (92 kDa gelatinase) in vitreous fluid of patients with proliferative diabetic retinopathy. Life Sci. 64: 2307-2315.
336. Kossakowska, A. E., Urbanski, S. J., Watson, A., Hayden, L. J., and Edwards, D. R. 1993. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res. 5: 19-28.
337. Kridel, S. J., Chen, E., Kotra, L. P., Howard, E. W., Mobashery, S., and Smith, J. W. 2001. Substrate hydrolysis by matrix metalloproteinase-9. J. Biol. Chem. 276: 20572-20578.
338. Kubota, S., Fridman, R., and Yamada, Y. 1991. Transforming growth factor-beta suppresses the invasiveness of human fibrosarcoma cells in vitro by increasing expression of tissue inhibitor of metalloprotease. Biochem. Biophys. Res. Commun. 176: 129-136.
339. Kubota, S., Takeda, K., Yamada, T., Nomura, Y., Takeda, M., Iwamoto, S., and Seyama, Y. 1996. Tumor necrosis factor alpha and lymphotoxin stimulate human myeloblastic leukemia cell (ML-1) invasion through a reconstituted basement membrane (Matrigel) with concomitant induction of 92 kDa gelatinase secretion. Cancer Lett. 98: 233-240.
340. Kubota, S., Ito, H., Ishibashi, Y., and Seyama, Y. 1997. Anti-alpha3 integrin antibody induces the activated form of matrix metalloprotease-2 (MMP-2) with concomitant stimulation of invasion through matrigel by human rhabdomyosarcoma cells. Int. J. Cancer 70: 106-111.
341. Kumar, A., Dhawan, S., Mukhopadhyay, A., and Aggarwal, B. B. 1999. Human immunodeficiency virus-1-tat induces matrix metalloproteinase-9 in monocytes through protein tyrosine phosphatase-mediated activation of nuclear transcription factor NF-kappaB. FEBS Lett. 462: 140-144.
342. Kurata, H., Thant, A. A., Matsuo, S., Senga, T., Okazaki, K., Hotta, N., and Hamaguchi, M. 2000. Constitutive activation of MAP kinase kinase (MEK1) is critical and sufficient for the activation of MMP-2. Exp. Cell Res. 254: 180-188.
343. Kurogi, T., Nabeshima, K., Kataoka, H., Okada, Y., and Koono, M. 1996. Stimulation of gelatinase B and tissue inhibitors of metalloproteinase (TIMP) production in co-culture of human osteosarcoma cells and human fibroblasts: gelatinase B production was stimulated via up-regulation of fibroblast growth factor (FGF) receptor. Int. J. Cancer 66: 82-90.
344. Lacraz, S., Dayer, J. M., Nicod, L., and Welgus, H. G. 1994a. 1,25-dihydroxyvitamin D3 dissociates production of interstitial collagenase and 92-kDa gelatinase in human mononuclear phagocytes. J. Biol. Chem. 269: 6485-6490.
345. Lacraz, S., Isler, P., Vey, E., Welgus, H. G., and Dayer, J. M. 1994b. Direct contact between T lymphocytes and monocytes is a major pathway for induction of metalloproteinase expression. J. Biol. Chem. 269: 22027-22033.
346. Lacraz, S., Nicod, L., Galve-de Rochemonteix, B., Baumberger, C., Dayer, J. M., and Welgus, H. G. 1992. Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4. J. Clin. Invest. 90: 382-388.
347. Lacraz, S., Nicod, L. P., Chicheportiche, R., Welgus, H. G., and Dayer, J. M. 1995. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 96: 2304-2310.
348. La Fleur, M., Underwood, J. L., Rappolee, D. A., and Werb, Z. 1996. Basement membrane and repair of injury to peripheral nerve: defining a potential role for macrophages, matrix metalloproteinases, and tissue inhibitor of metalloproteinases-1. J. Exp. Med. 184: 2311-2326.
349. Lafrenie, R. M., Wahl, L. M., Epstein, J. S., Hewlett, I. K., Yamada, K. M., and Dhawan, S. 1996. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J. Immunol. 156: 1638-1645.
350. Lafrenie, R. M., Wahl, L. M., Epstein, J. S., Yamada, K. M., and Dhawan, S. 1997. Activation of monocytes by HIV-Tat treatment is mediated by cytokine expression. J. Immunol. 159: 4077-4083.
351. Lakka, S. S., Jasti, S. L., Kyritsis, A. P., Yung, W. K., Ali-Osman, F., Nicolson, G. L., and Rao, J. S. 2000. Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades. Clin. Exp. Metastasis 18: 245-252.
352. Lambert, C. A., Colige, A. C., Munaut, C., Lapiere, C. M., and Nusgens, B. V. 2001. Distinct pathways in the over-expression of matrix metalloproteinases in human fibroblasts by relaxation of mechanical tension. Matrix Biol. 20: 397-408.
353. Lamoreaux, W. J., Fitzgerald, M. E., Reiner, A., Hasty, K. A., and Charles, S. T. 1998. Vascular endothelial growth factor increases release of gelatinase A and decreases release of tissue inhibitor of metalloproteinases by microvascular endothelial cells in vitro. Microvasc. Res. 55: 29-42.
354. Larjava, H., Lyons, J. G., Salo, T., Makela, M., Koivisto, L., Birkedal-Hansen, H., Akiyama, S. K., Yamada, K. M., and Heino, J. 1993. Anti-integrin antibodies induce type IV collagenase expression in keratinocytes. J. Cell Physiol. 157: 190-200.
355. Lauricella-Lefebvre, M. A., Castronovo, V., Sato, H., Seiki, M., French, D. L., and Merville, M. P. 1993. Stimulation of the 92-kD type IV collagenase promoter and enzyme expression in human melanoma cells. Invasion Metastasis 13: 289-300.
356. Leco, K. J., Edwards, D. R., and Schultz, G. A. 1996. Tissue inhibitor of metalloproteinases-3 is the major metalloproteinase inhibitor in the decidualizing murine uterus. Mol. Reprod. Dev. 45: 458-465.
357. Leco, K. J., Harvey, M. B., Hogan, A., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Edwards, D. R., and Schultz, G. A. 1997. Matrix metalloproteinase-9 maps to the distal end of chromosome 2 in the mouse. Dev. Genet. 21: 55-60.
358. Lee, E. R., Murphy, G., El-Alfy, M., Davoli, M. A., Lamplugh, L., Docherty, A. J., and Leblond, C. P. 1999a. Active gelatinase B is identified by histozymography in the cartilage resorption sites of developing long bones. Dev. Dyn. 215: 190-205.
359. Lee, M. A., Palace, J., Stabler, G., Ford, J., Gearing, A., and Miller, K. 1999b. Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study. Brain 122: 191-197.
360. Lefebvre, V., Peeters-Joris, C., and Vaes, G. 1991. Production of gelatin-degrading matrix metalloproteinases ('type IV collagenases') and inhibitors by articular chondrocytes during their dedifferentiation by serial subcultures and under stimulation by interleukin-1 and tumor necrosis factor alpha. Biochim. Biophys. Acta 1094: 8-18.
361. Legrand, C., Gilles, C., Zahm, J. M., Polette, M., Buisson, A. C., Kaplan, H., Birembaut, P., and Tournier, J. M. 1999. Airway epithelial cell migration dynamics. MMP-9 role in cell-extracellular matrix remodeling. J. Cell Biol. 146: 517-529.
362. Lei, H., Vadillo-Ortega, F., Paavola, L. G., and Strauss, J. F. 1995. 92-kDa gelatinase (matrix metalloproteinase-9) is induced in rat amnion immediately prior to parturition. Biol. Reprod. 53: 339-344.
363. Leppert, D., Ford, J., Stabler, G., Grygar, C., Lienert, C., Huber, S., Miller, K. M., Hauser, S. L., and Kappos, L. 1998. Matrix metalloproteinase-9 (gelatinase B) is selectively elevated in CSF during relapses and stable phases of multiple sclerosis. Brain 121: 2327-2334.
364. Leppert, D., Hauser, S. L., Kishiyama, J. L., An, S., Zeng, L., and Goetzl, E. J. 1995a. Stimulation of matrix metalloproteinase-dependent migration of T cells by eicosanoids. FASEB J. 9: 1473-1481.
365. Leppert, D., Waubant, E., Galardy, R., Bunnett, N. W., and Hauser, S. L. 1995b. T cell gelatinases mediate basement membrane transmigration in vitro. J. Immunol. 154: 4379-4389.
366. Leppert, D., Waubant, E., Bürk, M. R., Oksenberg, J. R., and Hauser, S. L. 1996. Interferon beta-1β inhibits gelatinase secretion and in vitro migration of human T cells: a possible mechanism for treatment efficacy in multiple sclerosis. Ann. Neurol. 40: 846-852.
367. Leppert, D., Hughes, P., Huber, S., Erne, B., Grygar, C., Said, G., Miller, K. M., Steck, A. J., Probst, A., and Fuhr, P. 1999. Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53: 62-70.
368. Levy, A. T., Cioce, V., Sobel, M. E., Garbisa, S., Grigioni, W. F., Liotta, L. A., and Stetler-Stevenson, W. G. 1991. Increased expression of the Mr 72,000 type IV collagenase in human colonic adenocarcinoma. Cancer Res. 51: 439-444.
369. Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, D., Galardy, R., Damsky, C. H., and Fisher, S. J. 1991. 92-kDa type IV collagenase mediates invasion of human cytotrophoblasts. J. Cell Biol. 113: 437-449.
370. Lichtinghagen, R., Seifert, T., Kracke, A., Marckmann, S., Wurster, U., and Heidenreich, F. 1999. Expression of matrix metalloproteinase-9 and its inhibitors in mononuclear blood cells of patients with multiple sclerosis. J. Neuroimmunol. 99: 19-26.
371. Lijnen, H. R., Lupu, F., Moons, L., Carmeliet, P., Goulding, D., and Collen, D. 1999. Temporal and topographic matrix metalloproteinase expression after vascular injury in mice. Thromb. Haemost. 81: 799-807.
372. Lim, G. P., Backstrom, J. R., Cullen, M. J., Miller, C. A., Atkinson, R. D., and Tökés, Z. A. 1996. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. J. Neurochem. 67: 251-259.
373. Lim, G. P., Russell, M. J., Cullen, M. J., and Tökés, Z. A. 1997. Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics. J. Neurochem. 68: 1606-1611.
374. Lin, T. H., Aplin, A. E., Shen, Y., Chen, Q., Schaller, M., Romer, L., Aukhil, I., and Juliano, R. L. 1997. Integrin-mediated activation of MAP kinase is independent of FAK: evidence for dual integrin signaling pathways in fibroblasts. J. Cell Biol. 136: 1385-1395.
375. Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. 2000. Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J. 345: 401-415.
376. Liu, E., Thant, A. A., Kikkawa, F., Kurata, H., Tanaka, S., Nawa, A., Mizutani, S., Matsuda, S., Hanafusa, H., and Hamaguchi, M. 2000a. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1. Cancer Res. 60: 2361-2364.
377. Liu, Z., Shipley, J. M., Vu, T. H., Zhou, X., Diaz, L. A., Werb, Z., and Senior, R. M. 1998. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J. Exp. Med. 188: 475-482.
378. Liu, Z., Zhou, X., Shapiro, S. D., Shipley, J. M., Twining, S. S., Diaz, L. A., Senior, R. M., and Werb, Z. 2000b. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell 102: 647-655.
379. Liuzzi, G. M., Santacroce, M. P., Peumans, W. J., Van Damme, E., Dubois, B., Opdenakker, G., and Riccio, P. 1999. Regulation of gelatinases in microglia and astrocyte cell cultures by plant lectins. Glia 27: 53-61.
380. Llano, E., Pendas, A. M., Freije, J. P., Nakano, A., Knauper, V., Murphy, G., and Lopez-Otin, C. 1999. Identification and characterization of human MT5-MMP, a new membrane-bound activator of progelatinase a overexpressed in brain tumors. Cancer Res. 59: 2570-2576.
381. Llorens, A., Rodrigo, I., Lopez-Barcons, L., Gonzalez-Garrigues, M., Lozano, E., Vinyals, A., Quintanilla, M., Cano, A., and Fabra, A. 1998. Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression. Lab. Invest. 78: 1131-1142.
382. Lohi, J., Harvima, I., and Keski-Oja, J. 1992. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin. J. Cell Biochem. 50: 337-349.
383. Lou, J., Gasche, Y., Zheng, L., Giroud, C., Morel, P., Clements, J., Ythier, A., and Grau, G. E. 1999. Interferon-β inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Lab. Invest. 79: 1015-1025.
384. Luo, J., Lubaroff, D. M., and Hendrix, M. J. 1999. Suppression of prostate cancer invasive potential and matrix metalloproteinase activity by E-cadherin transfection. Cancer Res. 59: 3552-3556.
385. Ma, Z., Qin, H., and Benveniste, E. N. 2001. Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-gamma and IFN-beta: critical role of STAT-1alpha. J. Immunol. 167: 5150-5159.
386. MacDougall, J. R., Bani, M. R., Lin, Y., Rak, J., and Kerbel, R. S. 1995. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res. 55: 4174-4181.
387. MacDougall, J. R. and Kerbel, R. S. 1995. Constitutive production of 92-kDa gelatinase B can be suppressed by alterations in cell shape. Exp. Cell Res. 218: 508-515.
388. Mackay, A. R., Hartzler, J. L., Pelina, M. D., and Thorgeirsson, U. P. 1990. Studies on the ability of 65-kDa and 92-kDa tumor cell gelatinases to degrade type IV collagen. J. Biol. Chem. 265: 21929-21934.
389. Mackay, A. R., Ballin, M., Pelina, M. D., Farina, A. R., Nason, A. M., Hartzler, J. L., and Thorgeirsson, U. P. 1992. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12: 168-184.
390. Madri, J. A., Graesser, D., and Haas, T. 1996. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem. Cell Biol. 74: 749-757.
391. Maeda, A. and Sobel, R. A. 1996. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions. J. Neuropathol. Exp. Neurol. 55: 300-309.
392. Maeda, S., Haneda, M., Guo, B., Koya, D., Hayashi, K., Sugimoto, T., Isshiki, K., Yasuda, H., Kashiwagi, A., and Kikkawa, R. 2001. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy. Kidney Int. 60: 1428-1434.
393. Mäkelá, M., Salo, T., Uitto, V.-J., and Larjava, H. 1994. Matrix metalloproteinases (MMP-2 and MMP-9) of the oral cavity: cellular origin and relationship to periodontal status. J. Dent. Res. 73: 1397-1406.
394. Mäkelä, M., Salo, T., and Larjava, H. 1998. MMP-9 from TNF alpha-stimulated keratinocytes binds to cell membranes and type I collagen: a cause for extended matrix degradation in inflammation? Biochem. Biophys. Res. Commun. 253: 325-335.
395. Malik, N., Greenfield, B. W., Wahl, A. F., and Kiener, P. A. 1996. Activation of human monocytes through CD40 induces matrix metalloproteinases. J. Immunol. 156: 3952-3960.
396. Marbaix, E., Donnez, J., Courtoy, P. J., and Eeckhout, Y. 1992. Progesterone regulates the activity of collagenase and related gelatinases A and B in human endometrial explants. Proc. Natl. Acad. Sci. U. S. A. 89: 11789-11793.
397. Marshall, B. C., Santana, A., Xu, Q. P., Petersen, M. J., Campbell, E. J., Hoidal, J. R., and Welgus, H. G. 1993. Metalloproteinases and tissue inhibitor of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J. Clin. Invest. 91: 1792-1799.
398. Marti, H. P., Lee, L., Kashgarian, M., and Lovett, D. H. 1994. Transforming growth factor-beta 1 stimulates glomerular mesangial cell synthesis of the 72-kd type IV collagenase. Am. J. Pathol. 144: 82-94.
399. Marti, H. P., McNeil, L., Davies, M., Martin, J., and Lovett, D. H. 1993. Homology cloning of rat 72 kDa type IV collagenase: cytokine and second-messenger inducibility in glomerular mesangial cells. Biochem. J. 291: 441-446.
400. Martin, J., Knowlden, J., Davies, M., and Williams, J. D. 1994. Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int. 46: 877-885.
401. Masure, S., Billiau, A., Van Damme, J., and Opdenakker, G. 1990. Human hepatoma cells produce an 85 kDa gelatinase regulated by phorbol 12-myristate 13-acetate. Biochim. Biophys. Acta 1054: 317-325.
402. Masure, S., Nys, G., Fiten, P., Van Damme, J., and Opdenakker, G. 1993. Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organization. Eur. J. Biochem. 218: 129-141.
403. Masure, S., Paemen, L., Van Aelst, I., Fiten, P., Proost, P., Billiau, A., Van Damme, J., and Opdenakker, G. 1997. Production and characterization of recombinant active mouse gelatinase B from eukaryotic cells and in vivo effects after intravenous administration. Eur. J. Biochem. 244: 21-30.
404. Masure, S., Proost, P., Van Damme, J., and Opdenakker, G. 1991. Purification and identification of 91-kDa neutrophil gelatinase. Release by the activating peptide interleukin-8. Eur. J. Biochem. 198: 391-398.
405. Matsubara, M., Girard, M. T., Kublin, C. L., Cintron, C., and Fini, M. E. 1991. Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodelling cornea. Dev. Biol. 147: 425-439.
406. Mattu, T. S., Royle, L., Langridge, J., Wormald, M. R., Van den Steen, P. E., Van Damme, J., Opdenakker, G., Harvey, D. J., Dwek, R. A., and Rudd, P. M. 2000. O-Glycan analysis of natural human neutrophil gelatinase B using a combination of normal phase-HPLC and online tandem mass spectrometry: implications for the domain organization of the enzyme. Biochemistry 39: 15695-15704.
407. Mautino, G., Oliver, N., Chanez, P., Bousquet, J., and Capony, F. 1997. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am. J. Respir. Cell Mol. Biol. 17: 583-591.
408. McCawley, L. J., Li, S., Wattenberg, E. V., and Hudson, L. G. 1999. Sustained activation of the mitogen-activated protein kinase pathway. A mechanism underlying receptor tyrosine kinase specificity for matrix metalloproteinase-9 induction and cell migration. J. Biol. Chem. 274: 4347-4353.
409. McCawley, L. J., O'Brien, P., and Hudson, L. G. 1998. Epidermal growth factor (EGF)- and scatter factor/hepatocyte growth factor (SF/HGF)- mediated keratinocyte migration is coincident with induction of matrix metalloproteinase (MMP)-9. J. Cell Physiol. 176: 255-265.
410. McLaughlin, B. and Weiss, J. B. 1996. Endothelial-cell-stimulating angiogenesis factor (ESAF) activates progelatinase A (72 kDa type IV collagenase), prostromelysin 1 and procollagenase and reactivates their complexes with tissue inhibitors of metalloproteinases: a role for ESAF in non-inflammatory angiogenesis. Biochem. J. 317: 739-745.
411. McMillan, J. I., Riordan, J. W., Couser, W. G., Pollock, A. S., and Lovett, D. H. 1996a. Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy. J. Clin. Invest. 97: 1094-1101.
412. McMillan, J. I., Weeks, R., West, J. W., Bursten, S., Rice, G. C., and Lovett, D. H. 1996b. Pharmacological inhibition of gelatinase B induction and tumor cell invasion. Int. J. Cancer 67: 523-531.
413. McMillan, W. D., Patterson, B. K., Keen, R. R., Shively, V. P., Cipollone, M., and Pearce, W. H. 1995. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler. Thromb. Vasc. Biol. 15: 1139-1144.
414. McQuibban, G. A., Butler, G. S., Gong, J. H., Bendall, L., Power, C., Clark-Lewis, I., and Overall, C. M. 2001. Matrix metalloproteinase activity inactivates the CXC chemokine stromal cell-derived factor-1. J. Biol. Chem. 276: 43503-43508.
415. Mehul, B., Bawumia, S., Martin, S. R., and Hughes, R. C. 1994. Structure of baby hamster kidney carbohydrate-binding protein CBP30, an S-type animal lectin. J. Biol. Chem. 269: 18250-18258.
416. Meikle, M. C., Bord, S., Hembry, R. M., Compston, J., Croucher, P. I., and Reynolds, J. J. 1992. Human osteoblasts in culture synthesize collagenase and other matrix metalloproteinases in response to osteotropic hormones and cytokines. J. Cell Sci. 103: 1093-1099.
417. Meng, X., Mavromatis, K., and Galis, Z. S. 1999. Mechanical stretching of human saphenous vein grafts induces expression and activation of matrix-degrading enzymes associated with vascular tissue injury and repair. Exp. Mol. Pathol. 66: 227-237.
418. Mertens, P. R., Alfonso-Jaume, M. A., Steinmann, K., and Lovett, D. H. 1998. A synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcription. J. Biol. Chem. 273: 32957-32965.
419. Mertens, P. R., Alfonso-Jaume, M. A., Steinmann, K., and Lovett, D. H. 1999. YB-1 regulation of the human and rat gelatinase A genes via similar enhancer elements. J. Am. Soc. Nephrol. 10: 2480-2487.
420. Mertz, P. M., Corcoran, M. L., McCluskey, K. M., Zhang, Y., Wong, H. L., Lotze, M. T., DeWitt, D. L., Wahl, S. M., and Wahl, L. M. 1996. Suppression of prostaglandin H synthase-2 induction in human monocytes by in vitro or in vivo administration of interleukin 4. Cell Immunol. 173: 252-260.
421. Mertz, P. M., DeWitt, D. L., Stetler-Stevenson, W. G., and Wahl, L. M. 1994. Interleukin 10 suppression of monocyte prostaglandin H synthase-2. Mechanism of inhibition of prostaglandin-dependent matrix metalloproteinase production. J. Biol. Chem. 269: 21322-21329.
422. Minafra, S., Giambelluca, C., Andriolo, M., and Pucci-Minafra, I. 1995. Cell-cell and cell-collagen interactions influence gelatinase production by human breast-carcinoma cell line 8701-BC. Int. J. Cancer 62: 777-783.
423. Misse, D., Estève, P. O., Renneboog, B., Vidal, M., Cerutti, M., St-Pierre, Y., Yssel, H., Parmentier, M., and Veas, F. 2001. HIV-1 glycoprotein 120 induces the MMP-9 cytopathogenic factor production that is abolished by inhibition of the p38 mitogen-activated protein kinase signaling pathway. Blood 98: 541-547.
424. Miyake, H., Yoshimura, K., Hara, I., Eto, H., Arakawa, S., and Kamidono, S. 1997. Basic fibroblast growth factor regulates matrix metalloproteinases production and in vitro invasiveness in human bladder cancer cell lines. J. Urol. 157: 2351-2355.
425. Miyaki, M., Tanaka, K., Kikuchi-Yanoshita, R., Muraoka, M., Konishi, M., and Takeichi, M. 1995. Increased cell-substratum adhesion, and decreased gelatinase secretion and cell growth, induced by E-cadherin transfection of human colon carcinoma cells. Oncogene 11: 2547-2552.
426. Miyazaki, K., Umenishi, F., Funahashi, K., Koshikawa, N., Yasumitsu, H., and Umeda, M. 1992. Activation of TIMP-2/progelatinase A complex by stromelysin. Biochem. Biophys. Res. Commun. 185: 852-859.
427. Mizoguchi, H., Komiyama, S., Matsui, K., Hamanaka, R., Ono, M., Kiue, A., Kobayashi, M., Shimizu, N., Welgus, H. G., and Kuwano, M. 1991. The response to epidermal growth factor of human maxillary tumor cells in terms of tumor growth, invasion and expression of proteinase inhibitors. Int. J. Cancer 49: 738-743.
428. Mohan, R., Sivak, J., Ashton, P., Russo, L. A., Pham, B. Q., Kasahara, N., Raizman, M. B., and Fini, M. E. 2000. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J. Biol. Chem. 275: 10405-10412.
429. Mohtai, M., Smith, R. L., Schurman, D. J., Tsuji, Y., Torti, F. M., Hutchinson, N. I., Stetler-Stevenson, W. G., and Goldberg, G. I. 1993. Expression of 92-kD type IV collagenase/gelatinase (gelatinase B) in osteoarthritic cartilage and its induction in normal human articular cartilage by interleukin 1. J. Clin. Invest. 92: 179-185.
430. Moll, U. M., Youngleib, G. L., Rosinski, K. B., and Quigley, J. P. 1990. Tumor promoter-stimulated Mr 92,000 gelatinase secreted by normal and malignant human cells: isolation and characterization of the enzyme from HT1080 tumor cells. Cancer Res. 50: 6162-6170.
431. Montgomery, A. M., Sabzevari, H., and Reisfeld, R. A. 1993. Production and regulation of gelatinase B by human T-cells. Biochim. Biophys. Acta 1176: 265-268.
432. Moore, D. H., Allison, B., Look, K. Y., Sutton, G. P., and Bigsby, R. M. 1997. Collagenase expression in ovarian cancer cell lines. Gynecol. Oncol. 65: 78-82.
433. Morgan, M. P., Cooke, M. M., Christopherson, P. A., Westfall, P. R., and McCarthy, G. M. 2001. Calcium hydroxyapatite promotes mitogenesis and matrix metalloproteinase expression in human breast cancer cell lines. Mol. Carcinog. 32: 111-117.
434. Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., and Tryggvason, K. 1999. Structure of human pro-matrix metalloproteinase-2: activation mechanism revealed. Science 284: 1667-1670.
435. Morini, M., Mottolese, M., Ferrari, N., Ghiorzo, F., Buglioni, S., Mortarini, R., Noonan, D. M., Natali, P. G., and Albini, A. 2000. The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87: 336-342.
436. Morodomi, T., Ogata, Y., Sasaguri, Y., Morimatsu, M., and Nagase, H. 1992. Purification and characterization of matrix metalloproteinase 9 from U937 monocytic leukaemia and HT1080 fibrosarcoma cells. Biochem. J. 285: 603-611.
437. Mostafa, M. E., Chollet-Martin, S., Oudghiri, M., Laquay, N., Jacob, M. P., Michel, J. B., and Feldman, L. J. 2001. Effects of interleukin-10 on monocyte/endothelial cell adhesion and MMP-9/TIMP-1 secretion. Cardiovasc. Res. 49: 882-890.
438. Mun-Bryce, S. and Rosenberg, G. A. 1998. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274: R1203-R1211.
439. Munaut, C., Noel, A., Weidle, U. H., Krell, H. W., and Foidart, J. M. 1995. Modulation of the expression of interstitial and type-IV collagenases in coculture of HT1080 fibrosarcoma cells and fibroblasts. Invasion Metastasis 15: 169-178.
440. Murphy, G. and Docherty, A. J. P. 1992. The matrix metalloproteinases and their inhibitors. Am. J. Respir. Cell Mol. Biol. 7: 120-125.
441. Murphy, G., Houbrechts, A., Cockett, M. I., Williamson, R. A., O'Shea, M., and Docherty, A. J. 1991. The N-terminal domain of tissue inhibitor of metalloproteinases retains metalloproteinase inhibitory activity. Biochemistry 30: 8097-8102.
442. Murphy, G., Nguyen, Q., Cockett, M. I., Atkinson, S. J., Allan, J. A., Knight, C. G., Willenbrock, F., and Docherty, A. J. 1994. Assessment of the role of the fibronectin-like domain of gelatinase A by analysis of a deletion mutant. J. Biol. Chem. 269: 6632-6636.
443. Murphy, G. and Willenbrock, F. 1995. Tissue inhibitors of matrix metalloendopeptidases. Methods Enzymol. 248: 496-510.
444. Nagase, H., Enghild, J. J., Suzuki, K., and Salvesen, G. 1990. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry 29: 5783-5789.
445. Nagase, H. and Woessner, J. F. 1999. Matrix metalloproteinases. J. Biol. Chem. 274: 21491-21494.
446. Nakagawa, H. and Sakata, K. 1986. Partial purification and characterization of exudate gelatinase in the acute phase of carrageenin-induced inflammation in rats. J. Biochem. (Tokyo) 100: 1499-1506.
447. Nakahara, H., Nomizu, M., Akiyama, S. K., Yamada, Y., Yeh, Y., and Chen, W. T. 1996. A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. J. Biol. Chem. 271: 27221-27224.
448. Nakajima, M., Lotan, D., Baig, M. M., Carralero, R. M., Wood, W. R., Hendrix, M. J., and Lotan, R. 1989. Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res. 49: 1698-1706.
449. Nakano, A., Tani, E., Miyazaki, K., Yamamoto, Y., and Furuyama, J. 1995. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg. 83: 298-307.
450. 1 mice. Clin. Sci. 85: 295-301.
451. Nakamura, H., Fujii, Y., Ohuchi, E., Yamamoto, E., and Okada, Y. 1998. Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases. Eur. J. Biochem. 253: 67-75.
452. Nelimarkka, L. O., Nikkari, S. T., Ravanti, L. S., Kahari, V. M., and Jarvelainen, H. T. 1998. Collagenase-1, stromelysin-1 and 92 kDa gelatinase are associated with tumor necrosis factor-alpha induced morphological change of human endothelial cells in vitro. Matrix Biol. 17: 293-304.
453. Nelissen, I., Vandenbroeck, K., Fiten, P., Hillert, J., Olsson, T., Giovanna, M. M., and Opdenakker, G. 2000. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis. J. Neuroimmunol. 105: 58-63.
454. Nelissen, I., Dubois, B., Goris, A., Ronsse, I., Carton, H., and Opdenakker, G. 2002a. Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis. J. Neurol. Sci. 200: 43-48.
455. Nelissen, I., Ronsse, I., Van Damme, J., and Opdenakker, G. 2002b. Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta. J. Leukoc. Biol. 71: 89-98.
456. Netzel-Arnett, S., Sang, Q. X., Moore, W. G., Navre, M., Birkedal-Hansen, H., and Van Wart, H. E. 1993. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry 32: 6427-6432.
457. Nguyen, Q., Murphy, G., Hughes, C. E., Mort, J. S., and Roughley, P. J. 1993. Matrix metalloproteinases cleave at two distinct sites on human cartilage link protein. Biochem. J. 295: 595-598.
458. Nicholson, R., Murphy, G., and Breathnach, R. 1989. Human and rat malignant-tumor-associated mRNAs encode stromelysin-like metalloproteinases. Biochemistry 28: 5195-5203.
459. Nielsen, B. S., Timshel, S., Kjeldsen, L., Sehested, M., Pyke, C., Borregaard, N., and Dano, K. 1996. 92 kDa type IV collagenase (MMP-9) is expressed in neutrophils and macrophages but not in malignant epithelial cells in human colon cancer. Int. J. Cancer 65: 57-62.
460. Nirmala, C., Jasti, S. L., Sawaya, R., Kyritsis, A. P., Konduri, S. D., Ali-Osman, F., Rao, J. S., and Mohanam, S. 2000. Effects of radiation on the levels of MMP-2, MMP-9 and TIMP-1 during morphogenic glial-endothelial cell interactions. Int. J. Cancer 88: 766-771.
461. Nishizuka, Y. 1984. The role of protein kinase C in cell surface signal transduction and tumour promotion. Nature 308: 693-698.
462. Niu, J., Gu, X., Ahmed, N., Andrews, S., Turton, J., Bates, R., and Agrez, M. 2001. The alphaVbeta6 integrin regulates its own expression with cell crowding: implications for tumour progression. Int. J. Cancer 92: 40-48.
463. Niu, J., Gu, X., Turton, J., Meldrum, C., Howard, E. W., and Agrez, M. 1998. Integrin-mediated signalling of gelatinase B secretion in colon cancer cells. Biochem. Biophys. Res. Commun. 249: 287-291.
464. Niyibizi, C., Chan, R., Wu, J. J., and Eyre, D.. 1994. A 92 kDa gelatinase (MMP-9) cleavage site in native type V collagen. Biochem. Biophys. Res. Commun. 202: 328-333.
465. Nomura, H., Fujimoto, N., Seiki, M., Mai, M., and Okada, Y. 1996. Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas. Int. J. Cancer 69: 9-16.
466. Norga, K., Paemen, L., Masure, S., Dillen, C., Heremans, H., Billiau, A., Carton, H., Cuzner, L., Olsson, T., Van Damme, J., and Opdenakker, G. 1995, Prevention of acute autoimmune encephalomyelitis and abrogation of relapses in murine models of multiple sclerosis by the protease inhibitor D-penicillamine. Inflamm. Res. 44: 529-534.
467. Nuijens, J. H., Abbink, J. J., Wachtfogel, Y. T., Colman, R. W., Eerenberg, A. J., Dors, D., Kamp, A. J., van Schijndel, R. J., Thijs, L. G., and Hack, C. E. 1992. Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis. J. Lab. Clin. Med. 119: 159-168.
468. Ochieng, J., Fridman, R., Nangia-Makker, P., Kleiner, D. E., Liotta, L. A., Stetler-Stevenson, W. G., and Raz, A. 1994. Galectin-3 is a novel substrate for human matrix metalloproteinases-2 and -9. Biochemistry 33: 14109-14114.
469. O'Connell, J. P., Willenbrock, F., Docherty, A. J., Eaton, D., and Murphy, G. 1994. Analysis of the role of the COOH-terminal domain in the activation, proteolytic activity, and tissue inhibitor of metalloproteinase interactions of gelatinase B. J. Biol. Chem. 269: 14967-14973.
470. Ogata, Y., Enghild, J. J., and Nagase, H. 1992. Matrix metalloproteinase 3 (stromelysin) activates the precursor for the human matrix metalloproteinase 9. J. Biol. Chem. 267: 3581-3584.
471. Ogata, Y., Itoh, Y., and Nagase, H. 1995. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem. 270: 18506-18511.
472. Oh, L. Y., Larsen, P. H., Krekoski, C. A., Edwards, D, R., Donovan, F., Werb, Z., and Yong, V. W, 1999. Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J. Neurosci. 19: 8464-8475.
473. 2-microglobulin amyloidosis. Virchows Arch. 428: 37-46.
474. Oikarinen, A., Kylmäniemi, M., Autio-Harmainen, H., Autio, P., and Salo, T. 1993. Demonstration of 72-kDa and 92-kDa forms of type IV collagenase in human skin: variable expression in various blistering diseases, induction during re-epithelialization, and decrease by topical glucocorticoids. J. Invest. Dermatol. 101: 205-210.
475. Oikarinen, A., Salo, T., Ala-Kokko, L., and Tryggvason, K. 1987. Dexamethasone modulates the metabolism of type IV collagen and fibronectin in human basement-membrane-forming fibrosarcoma (HT-1080) cells. Biochem. J. 245: 235-241.
476. Oikarinen, A. I., Uitto, J., and Oikarinen, J. 1986. Glucocorticoid action on connective tissue: from molecular mechanisms to clinical practice. Med. Biol. 64: 221-230.
477. Okada, Y. and Nakanishi, I. 1989. Activation of matrix metalloproteinase 3 (stromelysin) and matrix metalloproteinase 2 ('gelatinase') by human neutrophil elastase and cathepsin G. FEBS Lett. 249: 353-356.
478. Okada, Y., Morodomi, T., Enghild, J. J., Suzuki, K., Yasui, A., Nakanishi, I., Salvesen, G., and Nagase, H. 1990a. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194: 721-730.
479. Okada, Y., Tsuchiya, H., Shimizu, H., Tomita, K., Nakanishi, I., Sato, H., Seiki, M., Yamashita, K., and Hayakawa, T, 1990b. Induction and stimulation of 92-kDa gelatinase/type IV collagenase production in osteosarcoma and fibrosarcoma cell lines by tumor necrosis factor alpha. Biochem. Biophys. Res. Commun. 171: 610-617.
480. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. 1992. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J. Biol. Chem. 267: 21712-21719.
481. Okada, Y., Naka, K., Kawamura, K., Matsumoto, T., Nakanishi, I., Fujimoto, N., Sato, H., and Seiki, M. 1995. Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption. Lab. Invest. 72: 311-322.
482. Okumura, Y., Sato, H., Seiki, M., and Kido, H. 1997. Proteolytic activation of the precursor of membrane type 1 matrix metalloproteinase by human plasmin. A possible cell surface activator. FEBS Lett. 402: 181-184.
483. Olson, M. W., Bernardo, M. M., Pietila, M., Gervasi, D. C., Toth, M., Kotra, L. P., Massova, I., Mobashery, S., and Fridman, R. 2000. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin-1. J. Biol. Chem. 275: 2661-2668.
484. Olson, M. W., Gervasi, D. C., Mobashery, S., and Fridman, R. 1997. Kinetic analysis of the binding of human matrix metalloproteinase-2 and -9 to tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2. J. Biol. Chem. 272: 29975-29983.
485. Olson, M. W., Toth, M., Gervasi, D. C., Sado, Y., Ninomiya, Y., and Fridman, R. 1998. High affinity binding of latent matrix metalloproteinase-9 to the α2(IV) chain of collagen IV. J. Biol. Chem. 273: 10672-10681.
486. Opdenakker, G., Masure, S., Grillet, B., and Van Damme J. 1991a. Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 10: 317-324.
487. Opdenakker, G. Masure, S., Proost, P., Billiau, A., and Van Damme, J. 1991b. Natural human monocyte gelatinase and its inhibitor. FEBS Lett. 284: 73-78.
488. Opdenakker, G., and Van Damme, J. 1992a. Cytokines and proteases in invasive processes: molecular similarities between inflammation and cancer. Cytokine 4: 251-258.
489. Opdenakker, G. and Van Damme, J. 1992b. Chemotactic factors, passive invasion and metastasis of cancer cells. Immunol. Today 13: 463-464.
490. Opdenakker, G. and Van Damme, J. 1994. Cytokine-regulated proteases in autoimmune diseases. Immunol. Today 15: 103-107.
491. Opdenakker, G., Van den Steen, P. E., Dubois B., Nelissen, I., Van Coillie, E., Masure, S., Proost, P., and Van Damme J. 2001a. Gelatinase B functions as regulator and effector in leukocyte biology. J. Leukoc. Biol. 69: 851-859.
492. Opdenakker, G., Van den Steen, P. E., and Van Damme, J. 2001b. Gelatinase B: a tuner and amplifier of immune functions. Trends. Immunol. 22: 571-579.
493. Osmers, R. G. W., Adelmann-Grill, B. C., Rath, W., Stuhlsatz, H. W., Tschesche, H., and Kuhn, W. 1995. Biochemical events in cervical ripening dilatation during pregnancy and parturition. J. Obstet. Gynaecol. 21: 185-194.
494. Overall, C. M. and Sodek, J. 1990. Concanavalin A produces a matrix-degradative phenotype in human fibroblasts. Induction and endogenous activation of collagenase, 72-kDa gelatinase, and Pump-1 is accompanied by the suppression of the tissue inhibitor of matrix metalloproteinases. J. Biol. Chem. 265: 21141-21151.
495. Overall, C. M., Wrana, J. L., and Sodek, J. 1989. Transforming growth factor-beta regulation of collagenase, 72 kDa-progelatinase, TIMP and PAI-1 expression in rat bone cell populations and human fibroblasts. Connect. Tissue Res. 20: 289-294.
496. Overall, C. M., Wrana, J. L., and Sodek, J. 1991. Transcriptional and post-transcriptional regulation of 72-kDa gelatinase/type IV collagenase by transforming growth factor-beta 1 in human fibroblasts. Comparisons with collagenase and tissue inhibitor of matrix metalloproteinase gene expression. J. Biol. Chem. 266: 14064-14071.
497. Owens, M. W., Milligan, S. A., Jourd'heuil, D., and Grisham, M. B. 1997. Effects of reactive metabolites of oxygen and nitrogen on gelatinase A activity. Am. J. Physiol. 273: L445-L450.
498. Özenci, V., Kouwenhoven, M., Teleshova, N., Pashenkov, M., Fredrikson, S., and Link, H. 2000. Multiple sclerosis: pro- and anti-inflammatory cytokines and metalloproteinases are affected differentially by treatment with IFN-beta. J. Neuroimmunol. 108: 236-243.
499. Özenci, V., Rinaldi, L., Teleshova, N., Matusevicius, D., Kivisäkk, P., Kouwenhoven, M., and Link, H. 1999. Metalloproteinases and their tissue inhibitors in multiple sclerosis. J. Autoimmun. 12: 297-303.
500. Paemen, L., Jansen, P. M., Proost, P., Van Damme, J., Opdenakker, G., Hack, E., and Taylor, F. B. 1997. Induction of gelatinase B and MCP-2 in baboons during sublethal and lethal bacteraemia. Cytokine 9: 412-415.
501. Paemen, L., Martens, E., Masure, S., and Opdenakker, G. 1995. Monoclonal antibodies specific for natural human neutrophil gelatinase B used for affinity purification, quantitation by two-site ELISA and inhibition of enzymatic activity. Eur. J. Biochem. 234: 759-765.
502. Paemen, L., Martens, E., Norga, K., Masure, S., Roets, E., Hoogmartens, J., and Opdenakker, G. 1996. The gelatinase inhibitory activity of tetracyclines and chemically modified tetracycline analogues as measured by a novel microtiter assay for inhibitors. Biochem. Pharmacol. 52: 105-111.
503. Paemen, L., Olsson, T., Söderström, M., Van Damme, J., and Opdenakker, G. 1994. Evaluation of gelatinases and IL-6 in the cerebrospinal fluid of patients with optic neuritis, multiple sclerosis and other inflammatory neurological diseases. Eur. J. Neurol. 1: 55-63.
504. Pardo, A., Barrios, R., Maldonado, V., Melendez, J., Perez, J., Ruiz, V., Segura-Valdez, L., Sznajder, J. I., and Selman, M. 1998. Gelatinases A and B are up-regulated in rat lungs by sub-acute hyperoxia: pathogenetic implications. Am. J. Pathol. 153: 833-844.
505. Pardo, A., Pérez-Ramos, J., Segura-Valdez, L., Ramírez, R., and Selman, M. 1999. Expression and localization of TIMP-1, TIMP-2, MMP-13, MMP-2, and MMP-9 in early and advanced experimental lung silicosis. Ann. N. Y. Acad. Sci. 878: 587-589.
506. Partridge, C. A., Phillips, P. G., Niedbala, M. J., and Jeffrey, J. J. 1997. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts. Am. J. Physiol. 272: L813-L822.
507. Patterson, B. C., and Sang, Q. A. 1997. Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272: 28823-28825.
508. Paul, R., Lorenzl, S., Koedel, U., Sporer, B., Vogel, U., Frosch, M., and Pfister, H. W. 1998. Matrix metalloproteinases contribute to the blood-brain barrier disruption during bacterial meningitis. Ann. Neurol. 44: 592-600.
509. Pei, D. and Weiss, S. J. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375: 244-247.
510. Pender, S. L., Salmela, M. T., Monteleone, G., Schnapp, D., McKenzie, C., Spencer, J., Fong, S., Saarialho-Kere, U., and MacDonald, T. T. 2000. Ligation of alpha4ss1 integrin on human intestinal mucosal mesenchymal cells selectively upregulates membrane type-1 matrix metalloproteinase and confers a migratory phenotype. Am. J. Pathol. 157: 1955-1962.
511. Pentland, A. P., Shapiro, S. D., and Welgus, H. G. 1995. Agonist-induced expression of tissue inhibitor of metalloproteinases and metalloproteinases by human macrophages is regulated by endogenous prostaglandin E2 synthesis. J. Invest. Dermatol. 104: 52-57.
512. Peppin, G. J. and Weiss, S. J. 1986. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc. Natl. Acad. Sci. U. S. A. 83: 4322-4326.
513. Pereira, R. C., Jorgetti, V., and Canalis, E. 1999. Triiodothyronine induces collagenase-3 and gelatinase B expression in murine osteoblasts. Am. J. Physiol. 277: E496-E504.
514. Perides, G., Charness, M. E., Tanner, L. M., Péter, O., Satz, N., Steere, A. C., and Klempner, M. S. 1998. Matrix metalloproteinases in the cerebrospinal fluid of patients with Lyme neuroborreliosis. J. Infect. Dis. 177: 401-408.
515. Peters, D. G., Kassam, A., St-Jean, P. L., Yonas, H., and Ferrell, R. E. 1999. Functional polymorphism in the matrix metalloproteinase-9 promoter as a potential risk factor for intracranial aneurysm. Stroke 30: 2612-2616.
516. Petersen, F., Ludwig, A., Flad, H. D., and Brandt, E. 1996. TNF-α renders human neutrophils responsive to plalelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J. Immunol. 156: 1954-1962.
517. Ploug, M., Ronne, E., Behrendt, N., Jensen, A. L., Blasi, F., and Dano, K. 1991. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266: 1926-1933.
518. Pollanen, P. J., Karhunen, P. J., Mikkelsson, J., Laippala, P., Perola, M., Penttila, A., Mattila, K. M., Koivula, T., and Lehtimaki, T. 2001. Coronary artery complicated lesion area is related to functional polymorphism of matrix metalloproteinase 9 gene: an autopsy study. Arterioscler. Thromb. Vasc. Biol. 21: 1446-1450.
519. Potier, M., Elliot, S. J., Tack, I., Lenz, O., Striker, G. E., Striker, L. J., and Karl, M. 2001. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J. Am. Soc. Nephrol. 12: 241-251.
520. Powell, W. C., and Matrisian, L. M. 1996. Complex roles of matrix metalloproteinases in tumor progression. Curr. Top. Microbiol. Immunol. 213: 1-21.
521. Price, J. T., Wilson, H. M., and Haites, N. E. 1996. Epidermal growth factor (EGF) increases the in vitro invasion, motility and adhesion interactions of the primary renal carcinoma cell line, A704. Eur. J. Cancer 32A: 1977-1982.
522. Price, S. J., Greaves, D. R., and Watkins, H. 2001. Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J. Biol. Chem. 276: 7549-7558.
523. Proost, P., De Wolf-Peeters, C., Conings, R., Opdenakker, G., Billiau, A., and Van Damme, J. 1993b. Identification of a novel granulocyte chemotactic protein (GCP-2) from human tumor cells. In vitro and in vivo comparison with natural forms of GRO, IP-10, and IL-8. J. Immunol. 150: 1000-1010.
524. Proost, P., Van Damme, J., and Opdenakker, G. 1993a. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein. Biochem. Biophys. Res. Commun. 192: 1175-1181.
525. Pruijt, J. F., Fibbe, W. E., Laterveer, L., Pieters, R. A., Lindley, I. J., Paemen, L., Masure, S., Willemze, R., and Opdenakker, G. 1999a. Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the metalloproteinase gelatinase B (MMP-9). Proc. Natl. Acad. Sci. U. S. A. 96: 10863-10868.
526. Pruijt, J. F., Willemze, R., and Fibbe, W. E. 1999b. Mechanisms underlying hematopoietic stem cell mobilization induced by the CXC chemokine interleukin-8. Curr. Opin. Hematol. 6: 152-158.
527. Pruijt, J. F., Verzaal, P., van Os, R., de Kruijf, E. J., van Schie, M. L., Mantovani, A., Vecchi, A., Lindley, I. J., Willemze, R., Starckx, S., Opdenakker, G., and Fibbe, W. E. 2002. Neutrophils are indispensable for hematopoietic stem cell mobilization induced by interleukin-8 in mice. Proc. Natl. Acad. Sci. U. S. A. 99: 6228-6233.
528. Puistola, U., Westerlund, A., Kauppila, A., and Turpeenniemi-Hujanen, T. 1995. Regulation of 72-kd type IV collagenase-matrix metalloproteinase-2 by estradiol and gonadotropin-releasing hormone agonist in human granulosalutein cells. Fertil. Steril. 64: 81-87.
529. Puyraimond, A., Weitzman, J. B., Babiole, E., and Menashi, S. 1999. Examining the relationship between the gelatinolytic balance and the invasive capacity of endothelial cells. J. Cell Sci. 112: 1283-1290.
530. r 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 52: 1336-1341.
531. Pyo, R., Lee, J. K., Shipley, J. M., Curci, J. A., Mao, D., Ziporin, S. J., Ennis, T. L., Shapiro, S. D., Senior, R. M., and Thompson, R. W. 2000. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J. Clin. Invest. 105: 1641-1649.
532. Qian, X., Wang, T. N., Rothman, V. L., Nicosia, R. F., and Tuszynski, G. P. 1997. Thrombospondin-1 modulates angiogenesis in vitro by up-regulation of matrix metalloproteinase-9 in endothelial cells. Exp. Cell Res. 235: 403-412.
533. Qin, H., Moellinger, J. D., Wells, A., Windsor, L. J., Sun, Y., and Benveniste, E. N. 1998. Transcriptional suppression of matrix metalloproteinase-2 gene expression in human astroglioma cells by TNF-alpha and IFN-gamma. J. Immunol. 161: 6664-6673.
534. Qin, H., Sun, Y., and Benveniste, E. N. 1999. The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells. J. Biol. Chem. 274: 29130-29137.
535. Qin, X., Chua, P. K., Ohira, R. H., and Bryant-Greenwood, G. D. 1997a. An autocrine/paracrine role of human decidual relaxin. II. Stromelysin-1 (MMP-3) and tissue inhibitor of matrix metalloproteinase-1 (TIMP-1). Biol. Reprod. 56: 812-820.
536. Qin, X., Garibay-Tupas, J., Chua, P. K., Cachola, L., and Bryant-Greenwood, G. D. 1997b. An autocrine/paracrine role of human decidual relaxin. I. Interstitial collagenase (matrix metalloproteinase-1) and tissue plasminogen activator. Biol. Reprod. 56: 800-811.
537. Quiding-Jarbrink, M., Smith, D. A., and Bancroft, G. J. 2001. Production of matrix metalloproteinases in response to mycobacterial infection. Infect. Immun. 69: 5661-5670.
538. Rademacher, T. W., Parekh, R. B., and Dwek, R. A. 1988. Glycobiology. Annu. Rev. Biochem. 57: 785-838.
539. Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., and Galis, Z. S. 1996. Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J. Clin. Invest. 98: 2572-2579.
540. Ramana, C. V., Chatterjee-Kishore, M., Nguyen, H., and Stark, G. R. 2000. Complex roles of Stat1 in regulating gene expression. Oncogene 19: 2619-2627.
541. Rantala-Ryhanen, S., Ryhanen, L., Nowak, F. V., and Uitto, J. 1983. Proteinases in human polymorphonuclear leukocytes. Purification and characterization of an enzyme which cleaves denatured collagen and a synthetic peptide with a Gly-Ile sequence. Eur. J. Biochem. 134: 129-137.
542. r 92,000 type IV collagenase in human brain tumors. Cancer Res. 53: 2208-2211.
543. Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Fuller, G. N., Stetler-Stevenson, W. G., Rao, V. H., Liotta, L. A., Nicolson, G. L., and Sawaya, R. E. 1996. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin. Exp. Metastasis 14: 12-18.
544. Rao, V. H., Singh, R. K., Delimont, D. C., Finnell, R. H., Bridge, J. A., Neff, J. R., Garvin, B. P., Picketing, D. L., Sanger, W. G., Buehler, B. A., and Schaefer, G. B. 1999. Transcriptional regulation of MMP-9 expression in stromal cells of human giant cell tumor of bone by tumor necrosis factor-alpha. Int. J. Oncol. 14: 291-300.
545. Ratzinger, G., Stoitzner, P., Ebner, S., Lutz, M. B., Layton, G. T., Rainer, C., Senior, R. M., Shipley, J. M., Fritsch, P., Schuler, G., and Romani, N. 2002 Matrix metalloproteinases 9 and 2 are necessary for the migration of Langerhans cells and dermal dendritic cells from human and murine skin. J. Immunol. 168: 4361-4371.
546. Reddy, K. B., Krueger, J. S., Kondapaka, S. B., and Diglio, C. A. 1999. Mitogen-activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP-9) in breast epithelial cells. Int. J. Cancer 82: 268-273.
547. Reich, R., Blumenthal, M., and Liscovitch, M. 1995. Role of phospholipase D in laminin-induced production of gelatinase A (MMP-2) in metastatic cells. Clin. Exp. Metastasis 13: 134-140.
548. Reponen, P., Leivo, I., Sahlberg, C., Apte, S. S., Olsen, B. R., Thesleff, I., and Tryggvason, K. 1995. 92-kDa type IV collagenase and TLMP-3, but not 72-kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev. Dyn. 202: 388-396.
549. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., and Tryggvason, K. 1994. High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development. J. Cell Biol. 124: 1091-1102.
550. Ricca, A., Biroccio, A., Del Bufalo, D., Mackay, A. R., Santoni, A., and Cippitelli, M. 2000. bcl-2 over-expression enhances NF-kappaB activity and induces MMP-9 transcription in human MCF7(ADR) breast-cancer cells. Int. J. Cancer 86: 188-196.
551. Rice, A. and Banda, M. J. 1995. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry 34: 9249-9256.
552. Ricou, B., Nicod, L., Lacraz, S., Welgus, H. G., Suter, P. M., and Dayer, J. M. 1996. Matrix metalloproteinases and TIMP in acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med. 154: 346-352.
553. Ries, C., Kolb, H., and Petrides, P. E. 1994. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal and phorbol ester-induced secretion. Blood 83: 3638-3646.
554. Riley, S. C., Leask, R., Chard, T., Wathen, N. C., Calder, A. A., and Howe, D. C. 1999. Secretion of matrix metalloproteinase-2, matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases into the intrauterine compartments during early pregnancy. Mol. Hum. Reprod. 5: 376-381.
555. Robinson, M. J. and Cobb, M. H. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9: 180-186.
556. Roche, P. C., Campeau, J. D., and Shaw, S. T. Jr. 1983. Comparative electrophoretic analysis of human and porcine plasminogen activators in SDS-polyacrylamide gels containing plasminogen and casein. Biochim. Biophys. Acta 745: 82-89.
557. Roldan, A. L., Cubellis, M. V., Masucci, M. T., Behrendt, N., Lund, L. R., Dano, K., Appella, E., and Blasi, F. 1990. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9: 467-474.
558. Romanic, A. M. and Madri, J. A. 1994. The induction of 72-kD gelatinase in T cells upon adhesion to endothelial cells is VCAM-1 dependent. J. Cell Biol. 125: 1165-1178.
559. Romanic, A. M., Harrison, S. M., Bao, W., Burns-Kurtis, C. L., Pickering, S., Gu, J., Grau, E., Mao, J., Sathe, G. M., Ohlstein, E. H., and Yue, T. L. 2002. Myocardial protection from ischemia/-reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc. Res. 54: 549-558.
560. Rosenberg, G. A., Dencoff, J. E., Correa, N., Reiners, M., and Ford, C. C. 1996a. Effect of steroids on CSF matrix metalloproteinases in multiple sclerosis: relation to blood-brain barrier injury. Neurology 46: 1626-1632.
561. Rosenberg, G. A., Dencoff, J. E., McGuire, P. G., Liotta, L. A., and Stetler-Stevenson, W. G. 1994. Injury-induced 92-kilodalton gelatinase and urokinase expression in rat brain. Lab. Invest. 71: 417-422.
562. Rosenberg, G. A., Estrada, E. Y., Dencoff, J. E., and Stetler-Stevenson, W. G. 1995. Tumor necrosis factor-α-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 703: 151-155.
563. Rosenberg, G. A., Navratil, M., Barone, F., and Feuerstein, G. 1996b. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J. Cereb. Blood Flow Metab. 16: 360-366.
564. Rousselle, A. V., Damiens, C., Grimaud, E., Fortun, Y., Padrines, M., Passuti, N., and Heymann, D. 2001. Potential synergies between matrix proteins and soluble factors on resorption and proteinase activities of rabbit bone cells. Histol. Histopathol. 16: 727-734.
565. Rowsell, S., Hawtin, P., Minshull, C. A., Jepson, H., Brockbank, S. M., Barratt, D. G., Slater, A. M., McPheat, W. L., Waterson, D., Henney, A. M. and Pauptit, R. A. 2002. Crystal structure of human MMP9 in complex with a reverse hydroxamate inhibitor. J. Mol. Biol. 319: 173-181.
566. Royle, L., Mattu, T. S., Hart, E., Langridge, J. I., Merry, A. H., Murphy, N., Harvey, D. J., Dwek, R. A., and Rudd, P. M. 2002. An analytical and structural database provides a strategy for sequencing o-glycans from microgram quantities of glycoproteins. Anal. Biochem. 304: 70-90.
567. Rudd, P. M. and Dwek, R. A. 1997. Glycosylation: heterogeneity and the 3D structure of proteins. Crit. Rev. Biochem. Mol. Biol. 32: 1-100.
568. Rudd, P. M., Mattu, T. S., Masure, S., Bratt, T., Van den Steen, P. E., Wormald, M. R., Küster, B., Harvey, D. J., Borregaard, N., Van Damme, J., Dwek, R. A., and Opdenakker, G. 1999. Glycosylation of natural human neutrophil gelatinase B and neutrophil gelatinase B-associated lipocalin. Biochemistry 38: 13937-13950.
569. Rydziel, S., Varghese, S., and Canalis, E. 1997. Transforming growth factor beta1 inhibits collagenase 3 expression by transcriptional and post-transcriptional mechanisms in osteoblast cultures. J. Cell Physiol. 170: 145-152.
570. Saad, S., Bendall, L. J., James, A., Gottlieb, D. J., and Bradstock, K. F. 2000. Induction of matrix metalloproteinases MMP-1 and MMP-2 by co-culture of breast cancer cells and bone marrow fibroblasts. Breast Cancer Res. Treat. 63: 105-115.
571. Saad, S., Gottlieb, D. J., Bradstock, K. F., Overall, C. M., and Bendall, L. J. 2002. Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. Cancer Res. 62: 283-289.
572. Saarialho-Kere, U. K., Welgus, H. G., and Parks, W. C. 1993. Distinct mechanisms regulate interstitial collagenase and 92-kDa gelatinase expression in human monocytic-like cells exposed to bacterial endotoxin. J. Biol. Chem. 268: 17354-17361.
573. Saarinen, J., Kalkkinen, N., Welgus, H. G., and Kovanen, P. T. 1994. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase. J. Biol. Chem. 269: 18134-18140.
574. Sahlberg, C., Reponen, P., Tryggvason, K., and Thesleff, I. 1999. Timp-1, -2 and -3 show coexpression with gelatinases A and B during mouse tooth morphogenesis. Eur. J. Oral Sci. 107: 121-130.
575. Sakalihasan, N., Delvenne, P., Nusgens, B. V., Limet, R., and Lapière, C. M. 1996. Activated forms of MMP-2 and MMP-9 in abdominal aortic aneurysms. J. Vasc. Surg. 24: 127-133.
576. Sakata, K., Maeda, T., and Nakagawa, H. 1989. Activation by cathepsin G of latent gelatinase secreted from rat polymorphonuclear leukocytes. Chem. Pharm. Bull. (Tokyo) 37: 1321-1323.
577. Salo, T., Huhtala, P., and Tryggvason, K. 1989. Modulation of type IV collagenase gene expression in human skin fibroblasts by TPA, TGF-beta and EGF-1. J. Cell Biochem. Suppl 13B: 96.
578. Salo, T., Lyons, J. G., Rahemtulla, F., Birkedal-Hansen, H., and Larjava, H. 1991. Transforming growth factor-beta 1 up-regulates type IV collagenase expression in cultured human keratinocytes. J. Biol. Chem. 266: 11436-11441.
579. Salo, T., Mäkelä, M., Kylmäniemi, M., Autio-Harmainen H., and Larjava, H. 1994. Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab. Invest. 70: 176-182.
580. Sang, Q. A., Bodden, M. K., and Windsor, L. J. 1996. Activation of human progelatinase A by collagenase and matrilysin: activation of procollagenase by matrilysin. J. Protein Chem. 15: 243-253.
581. Sang, Q. X., Thompson, E. W., Grant, D., Stetler-Stevenson, W. G., and Byers, S. W. 1991. Soluble laminin and arginine-glycine-aspartic acid containing peptides differentially regulate type IV collagenase messenger RNA, activation, and localization in testicular cell culture. Biol. Reprod. 45: 387-394.
582. Sang, Q. X., Birkedal-Hansen, H., and Van Wart, H. E. 1995. Proteolytic and non-proteolytic activation of human neutrophil progelatinase B. Biochim. Biophys. Acta 1251: 99-108.
583. Sang, Q. X. A. 1998. Complex role of matrix metalloproteinases in angiogenesis. Cell Res. 8: 171-177.
584. Santavicca, M., Noel, A., Angliker, H., Stoll, I., Segain, J. P., Anglard, P., Chretien, M., Seidah, N., and Basset, P. 1996. Characterization of structural determinants and molecular mechanisms involved in pro-stromelysin-3 activation by 4-aminophenylmercuric acetate and furin-type convertases. Biochem. J. 315: 953-958.
585. Saren, P., Welgus, H. G., and Kovanen, P. T. 1996. TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J. Immunol. 157: 4159-4165.
586. Sarret, Y., Woodley, D. T., Goldberg, G. S., Kronberger, A., and Wynn, K. C. 1992. Constitutive synthesis of a 92-kDa keratinocyte-derived type IV collagenase is enhanced by type I collagen and decreased by type IV collagen matrices. J. Invest. Dermatol. 99: 836-841.
587. Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., and Seiki, M. 1992. Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83.
588. Sato, H., Kita, M., and Seiki, M. 1993. v-Src activates the expression of 92-kDa type IV collagenase gene through the AP-1 site and the GT box homologous to retinoblastoma control elements. A mechanism regulating gene expression independent of that by inflammatory cytokines. J. Biol. Chem. 268: 23460-23468.
589. Sato, H. and Seiki, M. 1993. Regulatory mechanism of 92 kDa type IV collagenase gene expression which is associated with invasiveness of tumor cells. Oncogene 8: 395-405.
590. Sato, H., Kinoshita, T., Takino, T., Nakayama, K., and Seiki, M. 1996a. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2. FEBS Lett. 393: 101-104.
591. Sato, T., Ito, A., Ogata, Y., Nagase, H., and Mori, Y. 1996b. Tumor necrosis factor alpha (TNFalpha) induces promatrix metalloproteinase 9 production in human uterine cervical fibroblasts but interleukin 1 alpha antagonizes the inductive effect of TNFalpha. FEBS Lett. 392: 175-178.
592. Sato, T., Koike, L., Miyata, Y., Hirata, M., Mimaki, Y., Sashida, Y., Yano, M., and Ito, A. 2002. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT-1080 cells. Cancer Res. 62: 1025-1029.
593. Sawaya, R., Tofilon, P. J., Mohanam, S., Ali-Osman, F., Liotta, L. A., Stetler-Stevenson, W. G., and Rao, J. S. 1994. Induction of tissue-type plasminogen activator and 72-kDa type-IV collagenase by ionizing radiation in rat astrocytes. Int. J. Cancer 56: 214-218.
594. Schlessinger, J. 2000. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225.
595. Schnaper, H. W., Grant, D. S., Stetler-Stevenson, W. G., Fridman, R., D'Orazi, G., Murphy, A. N., Bird, R. E., Hoythya, M., Fuerst, T. R., French, D. L., Quigley, J. P., and Kleinman, H. K. 1993. Type IV collagenase(s) and TIMPs modulate endothelial cell morphogenesis in vitro. J. Cell Physiol. 156: 235-246.
596. Schönbeck, U., Mach, F., Sukhova, G. K., Murphy, C., Bonnefoy, J. Y., Fabunmi, R. P., and Libby, P. 1997. Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture? Circ. Res. 81: 448-454.
597. Schönbeck, U., Mach, F., and Libby, P. 1998. Generation of biologically active IL-1β by matrix metalloproteinases: a novel caspase-1-independent pathway of IL-1β processing. J. Immunol. 161: 3340-3346.
598. Schroen, D. J. and Brinckerhoff, C. E. 1996. Nuclear hormone receptors inhibit matrix metalloproteinase (MMP) gene expression through diverse mechanisms. Gene Exp. 6: 197-207.
599. Schwartz, J. D., Monea, S., Marcus, S. G., Patel, S., Eng, K., Galloway, A. C., Mignatti, P., and Shamamian, P. 1998. Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2. J. Surg. Res. 76: 79-85.
600. Seetharaman, J., Kanigsberg, A., Slaaby, R., Leffler, H., Barondes, S. H., and Rini, J. M. 1998. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2. 1-A resolution. J. Biol. Chem. 273: 13047-13052.
601. Seftor, R. E., Seftor, E. A., Gehlsen, K. R., Stetler-Stevenson, W. G., Brown, P. D., Ruoslahti, E., and Hendrix, M. J. 1992. Role of the alpha v beta 3 integrin in human melanoma cell invasion. Proc. Natl. Acad. Sci. U. S. A. 89: 1557-1561.
602. Seftor, R. E., Seftor, E. A., Stetler-Stevenson, W. G., and Hendrix, M. J. 1993. The 72 kDa type IV collagenase is modulated via differential expression of alpha v beta 3 and alpha 5 beta 1 integrins during human melanoma cell invasion. Cancer Res. 53: 3411-3415.
603. Segain, J. P., Harb, J., Gregoire, M., Meflah, K., and Menanteau, J. 1996. Induction of fibroblast gelatinase B expression by direct contact with cell lines derived from primary tumor but not from metastases. Cancer Res. 56: 5506-5512.
604. Sehgal, I. and Thompson, T. C. 1998. Neuropeptides induce Mr 92,000 type IV collagenase (matrix metalloprotease-9) activity in human prostate cancer cell lines. Cancer Res. 58: 4288-4291.
605. Sehgal, I. and Thompson, T. C. 1999. Novel regulation of type IV collagenase (matrix metalloproteinase-9 and -2) activities by transforming growth factor-beta1 in human prostate cancer cell lines. Mol. Biol. Cell 10: 407-416.
606. Sengelov, H., Kjeldsen, L., and Borregaard, N. 1993. Control of exocytosis in early neutrophil activation. J. Immunol. 150: 1535-1543.
607. Sengelov, H., Boulay, F., Kjeldsen, L., and Borregaard, N. 1994. Subcellular localization and translocation of the receptor for N-formylmethionyl-leucyl-phenylalanine in human neutrophils. Biochem. J. 299: 473-479.
608. Senior, R. M., Griffin, G. L., Fliszar, C. J., Shapiro, S. D., Goldberg, G. I., and Welgus, H. G. 1991. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266: 7870-7875.
609. Sepper, R., Konttinen, Y. T., Sorsa, T., and Koski, H. 1994. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest 106: 1129-1133.
610. Shankavaram, U. T., DeWitt, D. L., Funk, S. E., Sage, E. H., and Wahl, L. M. 1997. Regulation of human monocyte matrix metalloproteinases by SPARC. J. Cell Physiol. 173: 327-334.
611. Shankavaram, U. T., DeWitt, D. L., and Wahl, L. M. 1998. Lipopolysaccharide induction of monocyte matrix metalloproteinases is regulated by the tyrosine phosphorylation of cytosolic phospholipase A2. J. Leukoc. Biol. 64: 221-227.
612. Shao, Z. M., Wu, J., Shen, Z. Z., and Barsky, S. H. 1998. Genistein exerts multiple suppressive effects on human breast carcinoma cells. Cancer Res. 58: 4851-4857.
613. Shapiro, S. D., Campbell, E. J., Kobayashi, D. K., and Welgus, H. G. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86: 1204-1210.
614. Shapiro, S. D., Campbell, E. J., Kobayashi, D. K., and Welgus, H. G. 1991. Dexamethasone selectively modulates basal and lipopolysaccharide-induced metalloproteinase and tissue inhibitor of metalloproteinase production by human alveolar macrophages. J. Immunol. 146: 2724-2729.
615. Shapiro, S. D., Kobayashi, D. K., Pentland, A. P., and Welgus, H. G. 1993. Induction of macrophage metalloproteinases by extracellular matrix. Evidence for enzyme- and substrate-specific responses involving prostaglandin-dependent mechanisms. J. Biol. Chem. 268: 8170-8175.
616. Shapiro, S. D. 1994. Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease. Am. J. Respir. Crit. Care Med. 150: S160-S164.
617. Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M., and Welgus, H. G. 1995. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem. 270: 6351-6356.
618. Sharpe, R. M., Knobil, F., and Neill, J. P. Regulation of spermatogenesis. The Physiology of Reproduction 22, Raven Press, New York, 1994. 1363-1434.
619. Sheu, B. C., Hsu, S. M., Ho, H. N., Lien, H. C., Huang, S. C., and Lin, R. H. 2001. A novel role of metalloproteinase in cancer-mediated immunosuppression. Cancer Res. 61: 237-242.
620. Shi, Y., Patel, S., Niculescu, R., Chung, W., Desrochers, P., and Zalewski, A. 1999. Role of matrix metalloproteinases and their tissue inhibitors in the regulation of coronary cell migration. Arterioscler. Thromb. Vasc. Biol. 19: 1150-1155.
621. Shibata, K., Kikkawa, F., Nawa, A., Thant, A. A., Naruse, K., Mizutani, S., and Hamaguchi, M. 1998. Both focal adhesion kinase and c-Ras are required for the enhanced matrix metalloproteinase 9 secretion by fibronectin in ovarian cancer cells. Cancer Res. 58: 900-903.
622. Shima, I., Sasaguri, Y., Kusukawa, J., Nakano, R., Yamana, H., Fujita, H., Kakegawa, T., and Morimatsu, M. 1993. Production of matrix metalloproteinase 9 (92-kDa gelatinase) by human oesophageal squamous cell carcinoma in response to epidermal growth factor. Br. J. Cancer 67: 721-727.
623. Shimajiri, S., Arima, N., Tanimoto, A., Murata, Y., Hamada, T., Wang, K. -Y., and Sasaguri, Y. 1999. Shortened microsatellite d(CA)21 sequence down-regulates promoter activity of matrix metalloproteinase 9 gene. FEBS Lett. 455: 70-74.
624. Shimamori, Y., Watanabe, Y., and Fujimoto, Y. 1995. Characterization of gelatinases in human placenta. Biochem. Mol. Med. 56: 84-86.
625. Shimonovitz, S., Hurwitz, A., Hochner-Celnikier, D., Dushnik, M., Anteby, E., and Yagel, S. 1998. Expression of gelatinase B by trophoblast cells: down-regulation by progesterone. Am. J. Obstet. Gynecol. 178: 457-461.
626. Simon, C., Goepfert, H., and Boyd, D. 1998. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion. Cancer Res. 58: 1135-1139.
627. Simon, C., Hicks, M. J., Nemechek, A. J., Mehta, R., O'Malley, B. W., Jr., Goepfert, H., Flaitz, C. M., and Boyd, D. 1999. PD 098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma. Br. J. Cancer 80: 1412-1419.
628. Simon, C., Simon, M., Vucelic, G., Hicks, M. J., Plinkert, P. K., Koitschev, A., and Zenner, H. P. 2001. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation. Exp. Cell Res. 271: 344-355.
629. Singer, C. F., Marbaix, E., Lemoine, P., Courtoy, P. J., and Eeckhout, Y. 1999. Local cytokines induce differential expression of matrix metalloproteinases but not their tissue inhibitors in human endometrial fibroblasts. Eur. J. Biochem. 259: 40-45.
630. Singh, R. K., Gutman, M., Reich, R., and Bar-Eli, M. 1995. Ultraviolet B irradiation promotes tumorigenic and metastatic properties in primary cutaneous melanoma via induction of interleukin 8. Cancer Res. 55: 3669-3674.
631. Sires, U. I., Murphy, G., Baragi, V. M., Fliszar, C. J., Welgus, H. G., and Senior, R. M. 1994. Matrilysin is much more efficient than other matrix metalloproteinases in the proteolytic inactivation of α1-antitrypsin. Biochem. Biophys. Res. Commun. 204: 613-620.
632. Siwik, D. A., Pagano, P. J., and Colucci, W. S. 2001. Oxidative stress regulates collagen synthesis and matrix metalloproteinase activity in cardiac fibroblasts. Am. J. Physiol. Cell Physiol. 280: C53-C60.
633. Skinner, J. L., Riley, S. C., Gebbie, A. E., Glasier, A. F., and Critchley, H. O. D. 1999. Regulation of matrix metalloproteinase-9 in endometrium during the menstrual cycle and following administration of intrauterine levonorgestrel. Hum. Reprod. 14: 793-799.
634. Slaton, J. W., Karashima, T., Perrotte, P., Inoue, K., Kim, S. J., Izawa, J., Kedar, D., McConkey, D. J., Millikan, R., Sweeney, P., Yoshikawa, C., Shuin, T., and Dinney, C. P. 2001. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder. Clin. Cancer Res. 7: 2840-2853.
635. Smith, R. J., Justen, J. M., Ulrich, R. G., Lund, J. E., and Sam, L. M. 1992. Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor. Clin. Immunol. Immunopathol. 64: 135-144.
636. Smolian, H., Aurer, A., Sittinger, M., Zacher, J., Bernimoulin, J. P., Burmester, G. R., and Kolkenbrock, H. 2001. Secretion of gelatinases and activation of gelatinase A (MMP-2) by human rheumatoid synovial fibroblasts. Biol. Chem. 382: 1491-1499.
637. Soini, Y., Hurskainen, T., Höyhtyä, M., Oikarinen, A., and Autio-Harmainen, H. 1994. 72 KD and 92 KD type IV collagenase, type IV collagen, and laminin mRNAs in breast cancer: a study by in situ hybridization. J. Histochem. Cytochem. 42: 945-951.
638. Soini, Y., Salo, T., Oikarinen, A., and Autio-Harmainen, H. 1993. Expression of 72 kilodalton and 92 kilodalton type IV collagenase in malignant fibrous histiocytomas and dermatofibromas. Lab. Invest. 69: 305-311.
639. Somasundaram, K., Jayaraman, G., Williams, T., Moran, E., Frisch, S., and Thimmapaya, B. 1996. Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc. Natl. Acad. Sci. U. S. A. 93: 3088-3093.
640. Song, L., Porter, D. G., and Coomber, B. L. 1999. Production of gelatinases and tissue inhibitors of matrix metalloproteinases by equine ovarian stromal cells in vitro. Biol. Reprod. 60: 1-7.
641. Sopata, I. and Maslinski, S. 1991. Activation of the latent human neutrophil gelatinase by urea. Acta Biochim. Pol. 38: 67-70.
642. Sorbi, D., French, D. L., Nuovo, G. J., Kew, R. R., Arbeit, L. A., and Gruber, B. L. 1996. Elevated levels of 92-kd type IV collagenase (matrix metalloproteinase 9) in giant cell arteritis. Arthritis Rheum. 39: 1747-1753.
643. Sorsa, T., Salo, T., Koivunen, E., Tyynela, J., Konttinen, Y. T., Bergmann, U., Tuuttila, A., Niemi, E., Teronen, O., Heikkila, P., Tschesche, H., Leinonen, J., Osman, S., and Stenman, U. H. 1997. Activation of type IV procollagenases by human tumor-associated trypsin-2. J. Biol. Chem. 272: 21067-21074.
644. Spinucci, C., Zucker, S., Wieman, J. M., Lysik, R. M., Imhof, B., Ramamurthy, N., Liotta, L. A., and Nagase, H. 1988. Purification of a gelatin-degrading type IV collagenase secreted by ras oncogene-transformed fibroblasts. J. Natl. Cancer Inst. 80: 1416-1420.
645. Sporer, B., Paul, R., Koedel, U., Grimm, R., Wick, M., Goebel, F. D., and Pfister, H. -W. 1998. Presence of matrix metalloproteinase-9 activity in the cerebrospinal fluid of human immunodeficiency virus-infected patients. J. Infect. Dis. 178: 854-857.
646. Springer, T. A. 1994. Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
647. Ståhle-Bäckdahl, M., Inoue, M., Giudice, G. J., and Parks, W. C. 1994. 92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J. Clin. Invest. 93: 2022-2030.
648. Stanton, H., Gavrilovic, J., Atkinson, S. J., D'Ortho, M. P., Yamada, K. M., Zardi, L., and Murphy, G. 1998. The activation of ProMMP-2 (gelatinase A) by HT1080 fibrosarcoma cells is promoted by culture on a fibronectin substrate and is concomitant with an increase in processing of MT1-MMP (MMP-14) to a 45 kDa form. J. Cell Sci. 111: 2789-2798.
649. Stark, G. R., Kerr, I. M., Williams, B. R., Silverman, R. H., and Schreiber, R. D. 1998. How cells respond to interferons. Annu. Rev. Biochem. 67: 227-264.
650. Stearns, M. E. and Wang, M. 1992. Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res. 52: 3776-3781.
651. Stearns, M. E. and Wang, M. 1994. Immunoassays of the metalloproteinase (MMP-2) and tissue inhibitor of metalloproteinase (TIMP 1 and 2) levels in noninvasive and metastatic PC-3 clones: effects of taxol. Oncol. Res. 6: 195-201.
652. Steffensen, B., Bigg, H. F., and Overall, C. M. 1998. The involvement of the fibronectin type II-like modules of human gelatinase A in cell surface localization and activation. J. Biol. Chem. 273: 20622-20628.
653. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L, A. 1993. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol. 9: 541-573.
654. St Jean, P. L., Zhang, X. C., Hart, B. K., Lamlum, H., Webster, M. W., Steed, D. L., Henney, A. M., and Ferrell, R. E. 1995. Characterization of a dinucleotide repeat in the 92 kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann. Hum. Genet. 59: 17-24.
655. St-Pierre, Y., Desrosiers, M., Tremblay, P., Estève, P. -O., and Opdenakker, G. 1996. Flow cytometric analysis of gelatinase B (MMP-9) activity using immobilized fluorescent substrate on microspheres. Cytometry 25: 374-380.
656. Strongin, A. Y., Collier, I., Bannikov, G., Marmer, B. L., Grant, G. A., and Goldberg, G. I. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270: 5331-5338.
657. Stüve, O., Dooley, N. P., Uhm, J. H., Antel, J. P., Francis, G. S., Williams, G., and Yong, V. W. 1996. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann. Neurol. 40: 853-863.
658. Stüve, O., Chabot, S., Jung, S. S., Williams, G., and Yong, V. W. 1997. Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9. J. Neuroimmunol. 80: 38-46.
659. Sugiura, T. and Berditchevski, F. 1999. Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146: 1375-1389.
660. Sun, J. and Hemler, M. E. 2001. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. 61: 2276-2281.
661. Sundstrom, J. B., Mosunjac, M., Martinson, D. E., Bostik, P., Donahoe, R. M., Gravanis, M. B., and Ansari, A. A. 2001. Effects of norepinephrine, HIV type 1 infection, and leukocyte interactions with endothelial cells on the expression of matrix metalloproteinases. AIDS Res. Hum. Retroviruses 17: 1605-1614.
662. Suzuki, K., Enghild, J. J., Morodomi, T., Salvesen, G., and Nagase, H. 1990. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry 29: 10261-10270.
663. Suzuki, K., Lees, M., Newlands, G. F., Nagase, H., and Woolley, D. E. 1995. Activation of precursors for matrix metalloproteinases 1 (interstitial collagenase) and 3 (stromelysin) by rat mast-cell proteinases I and II. Biochem. J. 305: 301-306.
664. Sweet, M. J. and Hume, D. A. 1996. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 60: 8-26.
665. Takahashi, K., Eto, H., and Tanabe, K. K. 1999. Involvement of CD44 in matrix metalloproteinase-2 regulation in human melanoma cells. Int. J. Cancer 80: 387-395.
666. Takemura, M., Azuma, C., Kimura, T., Kanai, T., Saji, F., and Tanizawa, O. 1994. Type-IV collagenase and tissue inhibitor of metalloproteinase in ovarian cancer tissues. Int. J. Gynecol. Obstet. 46: 303-309.
667. Takemura, M., Azuma, C., Kimura, T., Tokugawa, Y., Miki, M., Ono, M., Saji, F., and Tanizawa, O. 1992. Malignant cell-specific gelatinase activity in human endometrial carcinoma. Cancer 70: 147-151.
668. Takeshita, H., Yoshizaki, T., Miller, W. E., Sato, H., Furukawa, M., Pagano, J. S., and Raab-Traub, N. 1999. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2. J. Virol. 73: 5548-5555.
669. Takino, T., Sato, H., Shinagawa, A., and Seiki, M. 1995. Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J. Biol. Chem. 270: 23013-23020.
670. Tamura, T., Nakanishi, T., Kimura, Y., Hattori, T., Sasaki, K., Norimatsu, H., Takahashi, K., and Takigawa, M. 1996. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology 137: 3729-3737.
671. Tanaka, A., Yamane, Y., and Matsuda, H. 2001. Mast cell MMP-9 production enhanced by bacterial lipopolysaccharide. J. Vet. Med. Sci. 63: 811-813.
672. Tanaka, H., Hojo, K., Yoshida, H., Yoshioka, T., and Sugita, K. 1993. Molecular cloning and expression of the mouse 105-kDa gelatinase cDNA. Biochem. Biophys. Res. Commun. 190: 732-740.
673. Tanaka, K., Iwamoto, Y., Ito, Y., Ishibashi, T., Nakabeppu, Y., Sekiguchi, M., and Sugioka, Y. 1995. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res. 55: 2927-2935.
674. Tanney, D. C., Feng, L., Pollock, A. S., and Lovett, D. H. 1998. Regulated expression of matrix metalloproteinases and TIMP in nephrogenesis. Dev. Dyn. 213: 121-129.
675. Teale, D. M., Khidair, I. A., Potter, C. W., and Rees, R. C. 1988. Modulation of type IV collagenase and plasminogen activator in a hamster fibrosarcoma by basement membrane components and lung fibroblasts. Br. J. Cancer 57: 475-480.
676. Templeton, N. S., and Stetler-Stevenson, W. G. 1991. Identification of a basal promoter for the human Mr 72,000 type IV collagenase gene and enhanced expression in a highly metastatic cell line. Cancer Res. 51: 6190-6193.
677. Thant, A. A., Nawa, A., Kikkawa, F., Ichigotani, Y., Zhang, Y., Sein, T. T., Amin, A. R., and Hamaguchi, M. 2000. Fibronectin activates matrix metalloproteinase-9 secretion via the MEK1-MAPK and the PI3K-Akt pathways in ovarian cancer cells. Clin. Exp. Metastasis 18: 423-428.
678. Thant, A. A., Serbulea, M., Kikkawa, F., Liu, E., Tomoda, Y., and Hamaguchi, M. 1997. c-Ras is required for the activation of the matrix metalloproteinases by concanavalin A in 3Y1 cells. FEBS Lett. 406: 28-30.
679. Thomas, G. J., Lewis, M. P., Hart, I. R., Marshall, J. F., and Speight, P. M. 2001 a. AlphaVbeta6 integrin promotes invasion of squamous carcinoma cells through up-regulation of matrix metalloproteinase-9. Int. J. Cancer 92: 641-650.
680. Thomas, G. J., Poomsawat, S., Lewis, M. P., Hart, I. R., Speight, P. M., and Marshall, J. F. 2001b. alpha v beta 6 integrin upregulates matrix metalloproteinase 9 and promotes migration of normal oral keratinocytes. J. Invest. Dermatol. 116: 898-904.
681. Thompson, R. W., Holmes, D. R., Mertens, R. A., Liao, S., Botney, M. D., Mecham, R. P., Welgus, H. G., and Parks, W. C. 1995. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J. Clin. Invest. 96: 318-326.
682. Tienari, J., Pertovaara, L., Saksela, O., Lehtonen, E., and Vartio, T. 1994. Increased expression of the matrix metalloproteinase 2 in differentiating Tera 2 human embryonal carcinoma cells. Int. J. Cancer 56: 219-223.
683. Tomasek, J. J., Halliday, N. L., Updike, D. L., Ahern-Moore, J. S., Vu, T. K., Liu, R. W., and Howard, E. W. 1997. Gelatinase A activation is regulated by the organization of the polymerized actin cytoskeleton. J. Biol. Chem. 272: 7482-7487.
684. Torii, A., Kodera, Y., Uesaka, K., Hirai, T., Yasui, K., Morimoto, T., Yamamura, Y., Kato, T., Hayakawa, T., Fujimoto, N., and Kito, T. 1997. Plasma concentration of matrix metalloproteinase 9 in gastric cancer. Br. J. Surg. 84: 133-136.
685. Toschi, E., Barillari, G., Sgadari, C., Bacigalupo, I., Cereseto, A., Carlei, D., Palladino, C., Zietz, C., Leone, P., Sturzl, M., Butto, S., Cafaro, A., Monini, P., and Ensoli, B. 2001. Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency vires-1 Tat protein and basic fibroblast growth factor. Mol. Biol. Cell 12: 2934-2946.
686. Trachtman, H., Futterweit, S., Garg, P., Reddy, K., and Singhal, P. C. 1996. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218: 704-708.
687. Triebel, S., Bläser, J., Reinke, H., Knauper, V., and Tschesche, H. 1992a. Mercurial activation of human PMN leukocyte type IV procollagenase (gelatinase). FEBS Lett. 298: 280-284.
688. Triebel, S., Bläser, J., Reinke, H., and Tschesche, H. 1992b. A 25-kDa alpha 2-microglobulin-related protein is a component of the 125-kDa form of human gelatinase. FEBS Lett. 314: 386-388.
689. Trocmé, C., Gaudin, P., Berthier, S., Barro, C., Zaoui, P., and Morel, F. 1998. Human B lymphocytes synthesize the 92-kDa gelatinase, matrix metalloproteinase-9. J. Biol. Chem. 273: 20677-20684.
690. Tryggvason, K., Huhtala, P., Hoyhtya, M., Hujanen, E., and Hurskainen, T. 1992. 70 K type IV collagenase (gelatinase). Matrix Suppl. 1: 45-50.
691. Tryggvason, K., Huhtala, P., Tuuttila, A., Chow, L., Keski-Oja, J., and Lohi, J. 1990. Structure and expression of type IV collagenase genes. Cell Differ. Dev. 32: 307-312.
692. Tsang, K. J. and Crowe, D. L. 2001. Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway. Int. J. Oncol. 18: 369-374.
693. Tschesche, H., Zolzer, V., Triebel, S., and Bartsch, S. 2001. The human neutrophil lipocalin supports the allosteric activation of matrix metalloproteinases. Eur. J. Biochem. 268: 1918-1928.
694. Turpeenniemi-Hujanen, T., Thorgeirsson, U. P., Rat, C. N., and Liotta, L. A. 1986. Laminin increases the release of type IV collagenase from malignant cells. J. Biol. Chem. 261: 1883-1889.
695. Tyagi, S. C., Kumar, S. G., Haas, S. J., Reddy, H. K., Voelker, D. J., Hayden, M. R., Demmy, T. L., Schmaltz, R. A., and Curtis, J. J. 1996. Post-transcriptional regulation of extracellular matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J. Mol. Cell Cardiol. 28: 1415-1428.
696. Tzinia, A. K., Kitsiou, P. V., Talamagas, A. A., Georgopoulos, A., and Tsilibary, E. C. 2002. Effects of collagen IV on neuroblastoma cell matrix-related functions. Exp. Cell Res. 274: 169-177.
697. Ueda, Y., Imai, K., Tsuchiya, H., Fujimoto, N., Nakanishi, I., Katsuda, S., Seiki, M., and Okada, Y. 1996. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion. Am. J. Pathol. 148: 611-622.
698. Uemura, S., Matsushita, H., Li, W., Glassford, A. J., Asagami, T., Lee, K. H., Harrison, D, G., and Tsao, P. S. 2001. Diabetes mellitus enhances vascular matrix metalloproteinase activity: role of oxidative stress. Circ. Res. 88: 1291-1298.
699. Ugwu, F., Lemmens, G., Collen, D., and Lijnen, HR., 2001, Matrix metalloproteinase deficiencies do not impair cell-associated fibrinolytic activity. Thromb. Res. 102: 61-69.
700. Uhm, J. H., Dooley, N. P., Villemure, J. G., and Yong, V. W. 1996. Glioma invasion in vitro: regulation by matrix metalloprotease-2 and protein kinase C. Clin. Exp. Metastasis 14: 421-433.
701. Uhm, J. H., Dooley, N. P., Oh, L. Y., and Yong, V. W. 1998. Oligodendrocytes utilize a matrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22: 53-63.
702. Umehara, F., Okada, Y., Fujimoto, N., Abe, M., Izumo, S., and Osame, M. 1998. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in HTLV-I-associated myelopathy. J. Neuropathol. Exp. Neurol. 57: 839-849.
703. Unemori, E. N., Ehsani, N., Wang, M., Lee, S., McGuire, J., and Amento, E. P. 1994. Interleukin-1 and transforming growth factor-alpha: synergistic stimulation of metalloproteinases, PGE2, and proliferation in human fibroblasts. Exp. Cell Res. 210: 166-171.
704. Unemori, E. N., Hibbs, M. S., and Amento, E. P. 1991. Constitutive expression of a 92-kD gelatinase (type V collagenase) by rheumatoid synovial fibroblasts and its induction in normal human fibroblasts by inflammatory cytokines. J. Clin. Invest. 88: 1656-1662.
705. Uria, J. A. and Lopez-Otin, C. 2000. Matrilysin-2, a new matrix metalloproteinase expressed in human tumors and showing the minimal domain organization required for secretion, latency, and activity. Cancer Res. 60: 4745-4751.
706. Vacca, A., Moretti, S., Ribatti, D., Pellegrino, A., Pimpinelli, N., Bianchi, B., Bonifazi, E., Ria, R., Serio, G., and Dammacco, F. 1997. Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur. J. Cancer 33: 1685-1692.
707. Vacca, A., Ria, R., Presta, M., Ribatti, D., Iurlaro, M., Merchionne,
708. Vadillo-Ortega, F., Gonzalez-Avila, G., Furth, E. E., Lei, H., Muschel, R. J., Stetler-Stevenson, W. G., and Strauss, J. F. 1995.92-kd type IV collagenase (matrix metalloproteinase-9) activity in human amniochorion increases with labor. Am. J. Pathol. 146: 148-156.
709. Vadillo-Ortega, F., Hernandez, A., Gonzalez-Avila, G., Bermejo, L., Iwata, K., and Strauss, J. F. 1996. Increased matrix metalloproteinase activity and reduced tissue inhibitor of metalloproteinases-1 levels in amniotic fluids from pregnancies complicated by premature rupture of membranes. Am. J. Obstet. Gynecol. 174: 1371-1376.
710. Van Coillie, E., Van, A., I, Wuyts, A., Vercauteren, R., Devos, R., Wolf-Peeters, C., Van Damme, J., and Opdenakker, G. 2001. Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a counter-current principle. Am. J. Pathol. 159: 1405-1414.
711. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 167: 1364-1376.
712. van den Brule, F. A., Engel, J., Stetler-Stevenson, W. G., Liu, F. T., Sobel, M. E., and Castronovo, V. 1992. Genes involved in tumor invasion and metastasis are differentially modulated by estradiol and progestin in human breast-cancer cells. Int. J. Cancer 52: 653-657.
713. van den Oord, J. J., Paemen, L., Opdenakker, G., and De Wolf-Peeters, C. 1997. Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am. J. Pathol. 151: 665-670.
714. Van den Steen, P., Rudd, P. M., Dwek, R. A., and Opdenakker, G. 1998a. Concepts and principles of O-linked glycosylation. Crit. Rev. Biochem. Mol. Biol. 33: 151-208.
715. Van den Steen, P., Rudd, P. M., Proost, P., Martens, E., Paemen, L., Küster, B., Van Damme, J., Dwek, R. A., and Opdenakker, G. 1998b. Oligosaccharides of recombinant mouse gelatinase B variants. Biochim. Biophys. Acta 1425: 587-598.
716. Van den Steen, P. E., Proost, P., Wuyts, A., Van Damme, J., Opdenakker, G. 2000. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact. Blood 96: 2673-2681.
717. Van den Steen, P. E., Opdenakker, G., Wormald, M. R., Dwek, R. A., and Rudd, P. M. 2001. Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim. Biophys. Acta 1528: 61-73.
718. Van den Steen, P. E., Proost, P., Grillet, B., Brand, D. D., Kang, A. H., Van Damme, J., and Opdenakker, G. 2002. Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 16: 379-389.
719. Van Ranst, M., Norga, K., Masure, S., Proost, P., Vandekerckhove, F., Auwerx, J., Van Damme, J., and Opdenakker, G. 1991. The cytokine-protease connection: identification of a 96-kD THP-1 gelatinase and regulation by interleukin-1 and cytokine inducers. Cytokine 3: 231-239.
720. Van Wart, H. E. and Birkedal-Hansen, H. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87: 5578-5582.
721. Van Zee, K. J., DeForge, L. E., Fischer, E., Marano, M. A., Kenney, J. S., Remick, D. G., Lowry, S. F., and Moldawer, L. L. 1991. IL-8 in septic shock, endotoxemia, and after IL-1 administration. J. Immunol. 146: 3478-3482.
722. Vecil, G. G., Larsen, P. H., Corley, S. M., Herx, L. M., Besson, A., Goodyer, C. G., and Yong, V. W. 2000. Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo. J. Neurosci. Res. 61: 212-224.
723. Vegeto, E., Bonincontro, C., Pollio, G., Sala, A., Viappiani, S., Nardi, F., Brusadelli, A., Viviani, B., Ciana, P., and Maggi, A. 2001. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J. Neurosci. 21: 1809-1818.
724. Vernillo, A. T., Ramamurthy, N. S., Lee, H. M., and Rifkin, B. R. 1990. The effect of phenytoin on collagenase and gelatinase activities in UMR 106-01 rat osteoblastic osteosarcoma cells. Matrix 10: 27-32.
725. Vidovszky, T. J., Cabanela, M. E., Rock, M. G., Berry, D. J., Morrey, B. F., and Bolander, M. E. 1998. Histologic and biochemical differences between osteolytic and nonosteolytic membranes around femoral components of an uncemented total hip arthroplasty. J. Arthroplasty 13: 320-330.
726. Vo, H. P., Lee, M. K., and Crowe, D. L. 1998. alpha2beta1 integrin signaling via the mitogen activated protein kinase pathway modulates retinoic acid-dependent tumor cell invasion and transcriptional downregulation of matrix metalloproteinase 9 activity. Int. J. Oncol. 13: 1127-1134.
727. Vos, C. M., Gartner, S., Ransohoff, R. M., McArthur, J. C., Wahl, L., Sjulson, L., Hunter, E., and Conant, K. 2000. Matrix metalloprotease-9 release from monocytes increases as a function of differentiation: implications for neuroinflammation and neurodegeneration. J. Neuroimmunol. 109: 221-227.
728. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., and Werb, Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93: 411-422.
729. Wahl, L. M., Corcoran, M, E., Mergenhagen, S. E., and Finbloom, D. S. 1990. Inhibition of phospholipase activity in human monocytes by IFN-gamma blocks endogenous prostaglandin E2-dependent collagenase production. J. Immunol. 144: 3518-3522.
730. Wahl, L. M. and Corcoran, M. L. 1993. Regulation of monocyte/macrophage metalloproteinase production by cytokines. J. Periodontol. 64: 467-473.
731. Wahl, S. M., Allen, J. B., Weeks, B. S., Wong, H. L., and Klotman, P. E. 1993. Transforming growth factor beta enhances integrin expression and type IV collagenase secretion in human monocytes. Proc. Natl. Acad. Sci. U. S. A. 90: 4577-4581.
732. Wallach-Dayan, S. B., Grabovsky, V., Moll, J., Sleeman, J., Herrlich, P., Alon, R., and Naor, D. 2001. CD44-dependent lymphoma cell dissemination: a cell surface CD44 variant, rather than standard CD44, supports in vitro lymphoma cell rolling on hyaluronic acid substrate and its in vivo accumulation in the peripheral lymph nodes. J. Cell Sci. 114: 3463-3477.
733. Wang, M., Qin, X., Mudgett, J. S., Ferguson, T. A., Senior, R. M., and Welgus, H. G. 1999. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc. Natl. Acad. Sci. U. S. A. 96: 6885-6889.
734. Wang, H., and Keiser, J. A. 2000. Hepatocyte growth factor enhances MMP activity in human endothelial cells. Biochem. Biophys. Res. Commun. 272: 900-905.
735. Wang, X., Jung, J., Asahi, M., Chwang, W., Russo, L., Moskowitz, M. A., Dixon, C. E., Fini, M. E., and Lo, E. H. 2000. Effects of matrix metalloproteinase-9 gene knock-out on morphological and motor outcomes after traumatic brain injury. J. Neurosci. 20: 7037-7042.
736. Warner, R. L., Beltran, L., Younkin, E. M., Lewis, C. S., Weiss, S. J., Varani, J., and Johnson, K. J. 2001. Role of stromelysin 1 and gelatinase B in experimental acute lung injury. Am. J. Respir. Cell Mol. Biol. 24: 537-544.
737. Wassenaar, A., Verschoor, T., Kievits, F., Den Hartog, M. T., Kapsenberg, M. L., Evens, V., and Snijders, A. 1999. CD40 engagement modulates the production of matrix metalloproteinases by gingival fibroblasts. Clin. Exp. Immunol. 115: 161-167.
738. Watabe, T., Yoshida, K., Shindoh, M., Kaya, M., Fujikawa, K., Sato, H., Seiki, M., Ishii, S., and Fujinaga, K. 1998. The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor. Int. J. Cancer 77: 128-137.
739. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. 1993. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell Sci. 104: 991-999.
740. Weckroth, M., Vaheri, A., Lauharanta, J., Sorsa, T., and Konttinen, Y. T. 1996. Matrix metalloproteinases, gelatinase and collagenase, in chronic leg ulcers. J. Invest. Dermatol. 106: 1119-1124.
741. Weeks, B. S., Klotman, M. E., Holloway, E., Stetler-Stevenson, W. G., Kleinman, H. K., and Klotman, P.E. 1993a. HIV-1 infection stimulates T cell invasiveness and synthesis of the 92-kDa type IV collagenase. AIDS Res. Hum. Retroviruses 9: 513-518.
742. Weeks, B. S., Schnaper, H. W., Handy, M., Holloway, E., and Kleinman, H. K. 1993b. Human T lymphocytes synthesize the 92 kDa type IV collagenase (gelatinase B). J. Cell Physiol. 157: 644-649.
743. Welgus, H. G., Campbell, E. J., Cury, J. D., Eisen, A. Z., Senior, R. M., Wilhelm, S. M., and Goldberg, G. I. 1990. Neutral metalloproteinases produced by human mononuclear phagocytes. Enzyme profile, regulation, and expression during cellular development. J. Clin. Invest. 86: 1496-1502.
744. Weng, H., Choi, S. Y., and Faller, D. V. 1995. The Moloney leukemia retroviral long terminal repeat trans-activates AP-1-inducible genes and AP-1 transcription factor binding. J. Biol. Chem. 270: 13637-13644.
745. Werb, Z., Mainardi, C. L., Vater, C. A., and Harris, E. D. J. 1977. Endogenous activation of latent collagenase by rheumatoid synovial cells. Evidence for a role of plasminogen activator. N. Engl. J. Med. 296: 1017-1023.
746. Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., and Damsky, C. H. 1989. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression. J. Cell Biol. 109: 877-889.
747. Werb, Z., Ashkenas, J., MacAuley, A., and Wiesen, J. F. 1996. Extracellular matrix remodeling as a regulator of stromal-epithelial interactions during mammary gland development, involution and carcinogenesis. Braz. J. Med. Biol. Res. 29: 1087-1097.
748. Weston, C. A. and Weeks, B. S. 1996. bFGF stimulates U937 cell adhesion to fibronectin and secretion of gelatinase B. Biochem. Biophys. Res. Commun. 228: 318-323.
749. Wielockx, B., Lannoy, K., Shapiro, S. D., Itoh, T., Itohara, S., Vandekerckhove, J., and Libert, C. 2001. Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy. Nat. Med. 7: 1202-1208.
750. Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., and Goldberg, G. I. 1989, SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase, which is identical to that secreted by normal human macrophages. J. Biol. Chem. 264: 17213-17221.
751. Williams, R. J., Smith, R. L., and Schurman, D. J. 1990. Septic arthritis. Staphylococcal induction of chondrocyte proteolytic activity. Arthritis Rheum. 33: 533-541.
752. Windsor, L. J., Grenett, H., Birkedal-Hansen, B., Bodden, M. K., Engler, J. A., and Birkedal-Hansen, H. 1993. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters. J. Biol. Chem. 268: 17341-17347.
753. Wingrove, C. S., Garr, E., Godsland, I. F., and Stevenson, J. C. 1998. 17beta-oestradiol enhances release of matrix metalloproteinase-2 from human vascular smooth muscle cells. Biochim. Biophys. Acta 1406: 169-174.
754. Winkler, M., Fischer, D. -C., Ruck, P., Marx, T., Kaiserling, E., Oberpichler, A., Tschesche, H., and Rath, W. 1999. Parturition at term: parallel increases in interleukin-8 and proteinase concentrations and neutrophil count in the lower uterine segment. Hum. Reprod. 14: 1096-1100.
755. Wize, J., Sopata, I., Smerdel, A., and Maslinski, S. 1998. Ligation of selectin L and integrin CD11b/CD18 (Mac-1) induces release of gelatinase B (MMP-9) from human neutrophils. Inflamm. Res. 47: 325-327.
756. Wu, A. J., Lafrenie, R. M., Park, C., Apinhasmit, W., Chen, Z. J., Birkedal, H. H., Yamada, K. M., Stetler, S. W., and Baum, B. J. 1997. Modulation of MMP-2 (gelatinase A) and MMP-9 (gelatinase B) by interferon-gamma in a human salivary gland cell line. J. Cell Physiol. 171: 117-124.
757. Wucherpfennig, A. L., Li, Y. -P., Stetler-Stevenson, W. G., Rosenberg, A. E., and Stashenko, P. 1994. Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts. J. Bone Miner. Res. 9: 549-556.
758. Wuyts A., Proost, P., and Van Damme J. 1998 Interleukin-8 and other CXC chemokines. In The Cytokine Handbook (Thomson, A., Ed) pp. 271-311, Academic Press, London, UK.
759. Wysocki, A. B., Kusakabe, A. O., Chang, S., and Tuan, T. -L. 1999. Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound. Repair Regen. 7: 154-165.
760. Wysocki, A. B., Staiano-Coico, L., and Grinnell, F. 1993. Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9. J. Invest. Dermatol. 101: 64-68.
761. Xia, M., Leppert, D., Hauser, S. L., Sreedharan, S. P., Nelson, P. J., Krensky, A. M., and Goetzl, E. J. 1996. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. J. Immunol. 156: 160-167.
762. Xie, B., Bucana, C. D., and Fidler, I. J. 1994a. Density-dependent induction of 92-kd type IV collagenase activity in cultures of A431 human epidermoid carcinoma cells. Am. J. Pathol. 144: 1058-1067.
763. Xie, B., Dong, Z., and Fidler, I. J. 1994b. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152: 3637-3644.
764. Xie, B., Laouar, A., and Huberman, E. 1998a. Fibronectin-mediated cell adhesion is required for induction of 92-kDa type IV collagenase/gelatinase (MMP-9) gene expression during macrophage differentiation. The signaling role of protein kinase C-beta. J. Biol. Chem. 273: 11576-11582.
765. Xie, B., Laouar, A., and Huberman, E. 1998b. Autocrine regulation of macrophage differentiation and 92-kDa gelatinase production by tumor necrosis factor-alpha via alpha5 beta1 integrin in HL-60 cells. J. Biol. Chem. 273: 11583-11588.
766. Xu, J., Kim, G. M., Ahmed, S. H., Xu, J., Yah, P., Xu, X. M., and Hsu, C. Y. 2001a. Glucocorticoid receptor-mediated suppression of activator protein-1 activation and matrix metalloproteinase expression after spinal cord injury. J. Neurosci. 21: 92-97.
767. Xu, P., Wang, Y., Piao, Y., Bai, S., Xiao, Z., Jia, Y., Luo, S., and Zhuang, L. 2001b. Effects of matrix proteins on the expression of matrix metalloproteinase-2, -9, and -14 and tissue inhibitors of metalloproteinases in human cytotrophoblast cells during the first trimester. Biol. Reprod. 65: 240-246.
768. Xu, X. P., Meisel, S. R., Ong, J. M., Kaul, S., Cercek, B., Rajavashisth, T. B., Sharifi, B., and Shah, P. K. 1999. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human monocyte-derived macrophages. Circulation 99: 993-998.
769. Yakubenko, V. P., Lobb, R. R., Plow, E. F., and Ugarova, T. P. 2000. Differential induction of gelatinase B (MMP-9) and gelatinase A (MMP-2) in T lymphocytes upon alpha(4)beta(1)-mediated adhesion to VCAM-1 and the CS-1 peptide of fibronectin. Exp. Cell Res. 260: 73-84.
770. Yan, C., Wang, H., and Boyd, D. D. 2001. KiSS-1 represses 92-kDa type IV collagenase expression by down-regulating NF-kappa B binding to the promoter as a consequence of Ikappa Balpha-induced block of p65/p50 nuclear translocation. J. Biol. Chem. 276: 1164-1172.
771. Yan, L., Moses, M. A., Huang, S., and Ingber, D. E. 2000. Adhesion-dependent control of matrix metalloproteinase-2 activation in human capillary endothelial cells. J. Cell Sci. 113: 3979-3987.
772. Yao, J., Xiong, S., Klos, K., Nguyen, N., Grijalva, R., Li, P., and Yu, D. 2001. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20: 8066-8074.
773. Yao, J., Xiong, S., Klos, K., Nguyen, N., Grijalva, R., Li, P., and Yu, D. 2001. Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-beta1 in human breast cancer cells. Oncogene 20: 8066-8074.
774. Yao, P. M., Maitre, B., Delacourt, C., Buhler, J. M., Harf, A., and Lafuma, C. 1997. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha. Am. J. Physiol. 273: L866-L874.
775. Yao, P.M., Maitre, B., Delacourt, C., Buhler, J.M., Harf, A., and Lafuma, C. 1997. Divergent regulation of 92-kDa gelatinase and TIMP-1 by HBECs in response to IL-1beta and TNF-alpha. Am. J. Physiol. 273: L866-L874.
776. Yao, P. M., Delclaux, C., D'Ortho, M. P., Maitre, B.. Harf, A., Lafuma, C. 1998. Cell-matrix interactions modulate 92-kD gelatinase expression by human bronchial epithelial cells. Am. J. Respir. Cell Mol. Biol. 18: 813-822
777. Yao, P. M., Lemjabbar, H., D'Ortho, M. P., Maitre, B., Gossett, P., Wallaert, B., and Lafuma, C. 1999. Balance between MMP-9 and TIMP-1 expressed by human bronchial epithelial cells: relevance to asthma. Ann. N. Y. Acad. Sci. 878: 512-514.
778. Yokoo, T. and Kitamura, M. 1996. Dual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am. J. Physiol. 270: F123-F130.
779. Yong, V. W., Power, C., Forsyth, P., and Edwards, D. R. 2001. Metalloproteinases in biology and pathology of the nervous system. Nat. Rev. Neurosci. 2: 502-511.
780. Yoon, S., Tromp, G., Vongpunsawad, S., Ronkainen, A., Juvonen, T., and Kuivaniemi, H. 1999. Genetic analysis of MMP3, MMP9, and PAI-1 in Finnish patients with abdominal aortic or intracranial aneurysms. Biochem. Biophys. Res. Commun. 265: 563-568.
781. Young, P. K. and Grinnell, F. 1994. Metalloproteinase activation cascade after burn injury: a longitudinal analysis of the human wound environment. J. Invest. Dermatol. 103: 660-664.
782. Yrjanheikki, J., Keinanen, R., Pellikka, M., Hokfelt, T., and Koistinaho, J. 1998. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc. Natl. Acad. Sci. U. S. A. 95: 15769-15774.
783. Yrjanheikki, J., Tikka, T., Keinanen, R., Goldsteins, G., Chan, P. H., and Koistinaho, J. 1999. A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window. Proc. Natl. Acad. Sci. U. S. A. 96: 13496-13500.
784. Yu, M., Sato, H., Seiki, M., Spiegel, S., and Thompson, E. W. 1997. Calcium influx inhibits MT1-MMP processing and blocks MMP-2 activation. FEBS Lett. 412: 568-572.
785. Yu, M., Sato, H., Seiki, M., and Thompson, E. W. 1995. Complex regulation of membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation by concanavalin A in MDA-MB-231 human breast cancer cells. Cancer Res. 55: 3272-3277.
786. Yu, Q. and Stamenkovic, I. 1999. Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion. Genes Dev. 13: 35-48.
787. Yu, Q. and Stamenkovic, I. 2000, Cell surface-localized matrix metalloproteinase-9 proteolyticaUy activates TGF-β and promotes tumor invasion and angiogenesis. Genes Dev. 14: 163-176.
788. Zahner, G., Harendza, S., Muller, E., Wolf, G., Thaiss, F., and Stahl, R. A. 1997. Prostaglandin E2 stimulates expression of matrix metalloproteinase 2 in cultured rat mesangial cells. Kidney Int. 51: 1116-1123.
789. Zeigler, M. E., Chi, Y., Schmidt, T., and Varani, J. 1999. Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes. J. Cell Physiol. 180: 271-284.
790. Zeng, G. and Millis, A. J. 1994. Expression of 72-kDa gelatinase and TIMP-2 in early and late passage human fibroblasts. Exp. Cell Res. 213: 148-155.
791. Zhang, B., Henney, A., Eriksson, P., Hamsten, A., Watkins, H., and Ye, S. 1999a. Genetic variation at the matrix metalloproteinase-9 locus on chromosome 20q12. 2-13. 1. Hum. Genet. 105: 418-423.
792. Zhang, B., Ye, S., Herrmann, S. -M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., Watkins, H., and Henney, A. M. 1999b. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation 99: 1788-1794.
793. Zhang, B., Dhillon, S., Geary, I., Howell, W. M., Iannotti, F., Day, I. N., and Ye, S. 2001. Polymorphisms in matrix metalloproteinase-1, -3, -9, and -12 genes in relation to subarachnoid hemorrhage. Stroke 32: 2198-2202.
794. Zhang, Y., McCluskey, K., Fujii, K., Wahl, L. M. 1998. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161: 3071-3076.
795. Zhao, Q. and Lee, F. S. 1999. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. J. Biol. Chem. 274: 8355-8358.
796. Zhou, H., Bernhard, E. J., Fox, F. E., and Billings, P. C. 1993. Induction of metalloproteinase activity in human T-lymphocytes. Biochim. Biophys. Acta 1177: 174-178.
797. Zhu, H. J. and Burgess, A. W. 2001. Regulation of transforming growth factor-beta signaling. Mol. Cell Biol. Res. Commun. 4: 321-330.
798. Zhu, Y. K., Liu, X., Wang, H., Kohyama, T., Wen, F. Q., Skold, C. M., and Rennard, S. I. 2001. Interactions between monocytes and smooth-muscle cells can lead to extracellular matrix degradation. J. Allergy Clin. Immunol. 108: 989-996.
799. r 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res. 53: 140-146.